+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Get PDF Full Texts from EurekaMag Chapter 46331

Chapter 46331 provides scholary research titles of which PDF Full Texts are available through EurekaMag.

Mancini, D.A.; Mendonça, R.M.; Mendonça, R.Z.; do Prado, J.A.; Andrade, C.de.M., 1998:
Immune response to vaccine against influenza in smokers, non-smokers and, in individuals holding respiratory complications

Tabin, R.; Berclaz, J.P.; Dupuis, G.; Peter, O., 1993:
Immune response to various antiviral vaccines

Enomoto, T.; Tochinai, S., 2000:
Immune response to "self" lens in Xenopus laevis enucleated during larval life

Mendoza-Sagaon, M.; Gitzelmann, C.A.; Herreman-Suquet, K.; Pegoli, W.; Talamini, M.A.; Paidas, C.N., 1998:
Immune response: effects of operative stress in a pediatric model

Smith, D., 2003:
Immune responses against HIV: what we want and what we get

Kerakawauchi, H.; Kurono, Y.; Mogi, G., 1997:
Immune responses against Streptococcus pyogenes in human palatine tonsils

Inchauspé, G.; Major, M.E.; Nakano, I.; Vivitski, L.; Maisonnas, M.; Trépo, C., 1998:
Immune responses against hepatitis C virus structural proteins following genetic immunisation

de Gruijl, T.D.; Bontkes, H.J.; Walboomers, J.M.; Coursaget, P.; Stukart, M.J.; Dupuy, C.; Kueter, E.; Verheijen, R.H.; Helmerhorst, T.J.; Duggan-Keen, M.F.; Stern, P.L.; Meijer, C.J.; Scheper, R.J., 1999:
Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. I. Differential T-helper and IgG responses in relation to HPV infection and disease outcome

Bontkes, H.J.; de Gruijl, T.D.; Walboomers, J.M.; Schiller, J.T.; Dillner, J.; Helmerhorst, T.J.; Verheijen, R.H.; Scheper, R.J.; Meijer, C.J., 1999:
Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. II. Systemic but not local IgA responses correlate with clearance of HPV-16

Aho, A.J.; Eskola, J.; Ekfors, T.; Manner, I.; Kouri, T.; Hollmen, T., 1998:
Immune responses and clinical outcome of massive human osteoarticular allografts

Trgovcich, J.; Stimac, D.; Polić, B.; Krmpotić, A.; Pernjak-Pugel, E.; Tomac, J.; Hasan, M.; Wraber, B.; Jonjić, S., 2001:
Immune responses and cytokine induction in the development of severe hepatitis during acute infections with murine cytomegalovirus

Giulian, D., 1998:
Immune responses and dementia

Mizukoshi, E.; Rehermann, B., 2002:
Immune responses and immunity in hepatitis C virus infection

van Sandick, J.W.; Gisbertz, S.S.; ten Berge, I.J.M.; Boermeester, M.A.; van der Pouw Kraan, T.C.T.M.; Out, T.A.; Obertop, H.; van Lanschot, J.Jan.B., 2002:
Immune responses and prediction of major infection in patients undergoing transhiatal or transthoracic esophagectomy for cancer

Kazanji, M.; Laurent, F.; Péry, P., 1994:
Immune responses and protective effect in mice vaccinated orally with surface sporozoite protein of Eimeria falciformis in ISCOMs

Rothel, J.S.; Lightowlers, M.W.; Seow, H.F.; Wood, P.R.; Rothel, L.J.; Heath, D.D.; Harrison, G.B., 1996:
Immune responses associated with protection in sheep vaccinated with a recombinant antigen from Taenia ovis

Warner, J.A.; Jones, C.A.; Jones, A.C.; Miles, E.A.; Francis, T.; Warner, J.O., 1997:
Immune responses during pregnancy and the development of allergic disease

McElrath, M.J.; Corey, L.; Berger, D.; Hoffman, M.C.; Klucking, S.; Dragavon, J.; Peterson, E.; Greenberg, P.D., 1994:
Immune responses elicited by recombinant vaccinia-human immunodeficiency virus (HIV) envelope and HIV envelope protein: analysis of the durability of responses and effect of repeated boosting

L.B.rgne, S.; L.G.and, R.; Michel, M.L.; Vaslin, B.; Boson, B.; Janvier, G.; Aubertin, A.M.; Dormont, D.; Rivière, Y., 2001:
Immune responses following simian/human immunodeficiency virus (SHIV) challenge of rhesus macaques after human immunodeficiency virus (HIV)-1 third variable domain (V3) loop-based genetic immunization

Devoĭno, L.V.; Al'perina, E.L.; Pavina, T.A., 2000:
Immune responses in C57BL/6J mice with the inverted pattern of behavior during social conflict

Li, A.; Cam, P.D.; Islam, D.; Minh, N.B.; Huan, P.T.; Rong, Z.C.; Karlsson, K.; Lindberg, G.; Lindberg, A.A., 1994:
Immune responses in Vietnamese children after a single dose of the auxotrophic, live Shigella flexneri Y vaccine strain SFL124

Orme, I.M., 1996:
Immune responses in animal models

Locher, C.P.; Sykes, K.F.; Blackbourn, D.J.; Johnston, S.A., 2003:
Immune responses in baboons vaccinated with HIV-2 genetic expression libraries

Villarreal-Ramos, B.; Manser, J.; Collins, R.A.; Dougan, G.; Chatfield, S.N.; Howard, C.J., 1998:
Immune responses in calves immunised orally or subcutaneously with a live Salmonella typhimurium aro vaccine

Ahlborg, N.; Andersson, R.; Perlmann, P.; Berzins, K., 1996:
Immune responses in congenic mice to multiple antigen peptides based on defined epitopes from the malaria antigen Pf332

Jenmalm, M.C., 1998:
Immune responses in early childhood in relation to the development of asthma

Schmitt, D.A.; Abbal, M.; Rykova, M.; Meshkov, D.O., 2001:
Immune responses in extreme environments

Guo, H.; Chen, G.; Zheng, H.; Zhou, Y.; Lu, F., 2003:
Immune responses in mice vaccinated with recombinant plasmid pcDNA3 containing ROP1 gene from Toxoplasma gondii

Popović, M.; Popović, N.; Erić-Jovicić, M.; Jovanova-Nesić, K., 1999:
Immune responses in nucleus basalis magnocellularis-lesioned rats exposed to chronic isolation stress

Foon, K.A.; Oseroff, A.R.; Vaickus, L.; Greenberg, S.J.; Russell, D.; Bernstein, Z.; Pincus, S.; Köhler, H.; Seon, B.K.; Tahaoglu, E., 1995:
Immune responses in patients with T-cell lymphoma treated with an anti-idiotype antibody mimicking a highly restricted T-cell antigen

Bachmann, M.F.; Zinkernagel, R.M.; Oxenius, A., 1998:
Immune responses in the absence of costimulation: viruses know the trick

Beagley, K.W.; Wu, Z.L.; Pomering, M.; Jones, R.C., 2000:
Immune responses in the epididymis: implications for immunocontraception

Shigenaga, T.; Dannenberg, A.M.; Lowrie, D.B.; Said, W.; Urist, M.J.; Abbey, H.; Schofield, B.H.; Mounts, P.; Sugisaki, K., 2001:
Immune responses in tuberculosis: antibodies and CD4-CD8 lymphocytes with vascular adhesion molecules and cytokines (chemokines) cause a rapid antigen-specific cell infiltration at sites of bacillus Calmette-Guérin reinfection

Tamássy, K.; Auli, P.; Fekete, B.; Antonello, C., 1997:
Immune responses of IgG, IgA and anti-CagA IgG to Helicobacter pylori in dyspeptic and peptic ulcer patients

Banduwardene, R.; Mullen, A.B.; Carter, K.C., 1997:
Immune responses of Leishmania donovani infected BALB/c mice following treatment with free and vesicular sodium stibogluconate formulations

Huang, J.; Xie, Y.; Zhang, Q.; Shen, X.; Ren, D., 2003:
Immune responses of a recombined live Salmonella typhimurium SL3261 expressing a multi-epitope antigen of HCV

Sakamoto, N.; Kurono, Y.; Suzuki, M.; Kerakawauchi, H.; Mogi, G., 1998:
Immune responses of adenoidal lymphocytes specific to Haemophilus influenzae in the nasopharynx

Clery, D.; Torgerson, P.; Mulcahy, G., 1996:
Immune responses of chronically infected adult cattle to Fasciola hepatica

Guo, J.; Cai, M.; Wei, D.; Qin, L.; Huang, J.; Wang, X., 2002:
Immune responses of dendritic cells after loaded with cytotoxicity T lymphocyte epitope based peptide of human alpha-fetoprotein (hAFP)

van Diemen, P.M.; de Vries Reilingh, G.; Parmentier, H.K., 1994:
Immune responses of piglets to Pasteurella multocida toxin and toxoid

Honda, J.; Oizumi, K., 1999:
Immune responses of tuberculosis patients

Abrignani, S., 1997:
Immune responses throughout hepatitis C virus (HCV) infection: HCV from the immune system point of view

von Hertzen, L.; Surcel, H.M.; Kaprio, J.; Koskenvuo, M.; Bloigu, A.; Leinonen, M.; Saikku, P., 1999:
Immune responses to Chlamydia pneumoniae in twins in relation to gender and smoking

Kowalczyk, D.W.; Ertl, H.C., 1999:
Immune responses to DNA vaccines

Sjölander, A.; Drane, D.; Maraskovsky, E.; Scheerlinck, J.P.; Suhrbier, A.; Tennent, J.; Pearse, M., 2001:
Immune responses to ISCOM formulations in animal and primate models

Alonso, P.L.; Lopez, M.C.; Bordmann, G.; Smith, T.A.; Aponte, J.J.; Weiss, N.A.; Urassa, H.; Armstrong-Schellenberg, J.R.; Kitua, A.Y.; Masanja, H.; Thomas, M.C.; Oettli, A.; Hurt, N.; Hayes, R.; Kilama, W.L.; Tanner, M., 1998:
Immune responses to Plasmodium falciparum antigens during a malaria vaccine trial in Tanzanian children

DeMaria, A.; Kunches, L.; Mayer, K.; Cohen, C.; Epstein, P.; Werner, B.; Day, J.; DeCristofaro, J.; Landers, S.; Tang, Y.; Coady, W., 2000:
Immune responses to a recombinant human immunodeficiency virus type 1 (HIV-1) gpl60 vaccine among adults with advanced HIV infection. Massachusetts gp160 Working Group

Kajiwara, K.; Byrnes, A.P.; Charlton, H.M.; Wood, M.J.; Wood, K.J., 1997:
Immune responses to adenoviral vectors during gene transfer in the brain

L.V.lti, S.; Sciotto, A.; Fisichella, M.; Sciacca, A.; Munda, S.E.; Mangiagli, A.; L.V.lti, G.; Lupo, L., 1999:
Immune responses to administration of a vaccine against Haemophilus influenzae type B in splenectomized and non-splenectomized patients

Yadav, R.N.; Kabilan, L.; Singh, M.P.; Sharma, A., 2000:
Immune responses to chloroquine--sensitive and resistant populations of Plasmodium berghei in mice

Shore, S.; Shepard, R.J., 1999:
Immune responses to exercise in children treated for cancer

Kang, D.H.; Coe, C.L.; McCarthy, D.O.; Ershler, W.B., 1997:
Immune responses to final exams in healthy and asthmatic adolescents

Altamura, M.; Casale, D.; Pepe, M.; Tafaro, A., 2002:
Immune responses to fungal infections and therapeutic implications

Mancuso, M.; Caruso-Nicoletti, M.; Bianca, S.; Granata, G.; L.V.lti, G.; L.V.lti, S., 2001:
Immune responses to hepatitis B vaccine with and without the pre-S2 antigen in children with type 1 diabetes

Clements-Mann, M.L.; Weinhold, K.; Matthews, T.J.; Graham, B.S.; Gorse, G.J.; Keefer, M.C.; McElrath, M.J.; Hsieh, R.H.; Mestecky, J.; Zolla-Pazner, S.; Mascola, J.; Schwartz, D.; Siliciano, R.; Corey, L.; Wright, P.F.; Belshe, R.; Dolin, R.; Jackson, S.; Xu, S.; Fast, P.; Walker, M.C.; Stablein, D.; Excler, J.L.; Tartaglia, J.; Paoletti, E., 1998:
Immune responses to human immunodeficiency virus (HIV) type 1 induced by canarypox expressing HIV-1MN gp120, HIV-1SF2 recombinant gp120, or both vaccines in seronegative adults. NIAID AIDS Vaccine Evaluation Group

Looney, D.J., 1994:
Immune responses to human immunodeficiency virus type 1 in exposed but uninfected individuals: protection or chance?

Shephard, R.J.; Shek, P.N., 1998:
Immune responses to inflammation and trauma: a physical training model

Anonymous, 1998:
Immune responses to inflammation and trauma: a physical training module. Toronto, Ontario, Canada. July 10-11, 1997

Lindholm, A.; Jensen, L.B.; Home, P.D.; Raskin, P.; Boehm, B.O.; Råstam, J., 2002:
Immune responses to insulin aspart and biphasic insulin aspart in people with type 1 and type 2 diabetes

Kumar, K.; Singh, K.C.; Prasad, C.B., 2001:
Immune responses to intermediate strain IBD vaccine at different levels of maternal antibody in broiler chickens

Wakelin, D., 1998:
Immune responses to intestinal parasites: protection, pathology and prophylaxis

Thaithumyanon, P.; Punnahitananda, S.; Thisyakorn, U.; Praisuwanna, P.; Ruxrungtham, K., 2001:
Immune responses to measles immunization and the impacts on HIV-infected children

Hanano, R.; Kaufmann, S.H., 1998:
Immune responses to naturally acquired Pneumocystis carinii in gene disruption mutant mice

Feng, Z.; Zhou, Y.; Jia, Z.; Lian, J.; Li, J.; Li, W., 2002:
Immune responses to recombinant expression plasmid encoding hepatitis C virus core antigen

Rup, B., 2002:
Immune responses to recombinant factor IX (BeneFIX) and recombinant B domain deleted factor VIII (ReFacto)

Morral, N.; O'Neal, W.; Zhou, H.; Langston, C.; Beaudet, A., 1997:
Immune responses to reporter proteins and high viral dose limit duration of expression with adenoviral vectors: comparison of E2a wild type and E2a deleted vectors

Doherty, T.Mark.; Demissie, A.; Olobo, J.; Wolday, D.; Britton, S.; Eguale, T.; Ravn, P.; Andersen, P., 2002:
Immune responses to the Mycobacterium tuberculosis-specific antigen ESAT-6 signal subclinical infection among contacts of tuberculosis patients

Bansal, P.; Adegboye, D.S.; Rosenbusch, R.F., 1995:
Immune responses to the capsular polysaccharide of Mycoplasma dispar in calves and mice

Fang, Z.; Yu, X.; Liu, Y.; Luo, S., 2002:
Immune responses to the expressed products of the CSP antigen gene of plasmodium falciparum southern China isolate FCC1/HN in Hela cell

Koren, E.; Zuckerman, L.A.; Mire-Sluis, A.R., 2002:
Immune responses to therapeutic proteins in humans--clinical significance, assessment and prediction

Shore, S.; Shinkai, S.; Rhind, S.; Shephard, R.J., 1999:
Immune responses to training: how critical is training volume?

Arvin, A.M., 1996:
Immune responses to varicella-zoster virus

Moran, T.M., 2002:
Immune responses to viruses, bacteria, parasites and fungi in humans

Snider, A.; Nilsson, M.; Dupal, M.; Toloue, M.; Tripathi, A., 2018:
A Microfluidics Workflow for Sample Preparation for Next-Generation DNA Sequencing

Scornik, J.C.; Cecka, J.M., 1996:
Immune responsiveness and renal transplantation

Pernthaner, A.; Stankiewicz, M.; Cabaj, W.; Pfeffer, A.; Green, R.S.; Douch, P.G., 1996:
Immune responsiveness of nematode-resistant or susceptible Romney line-bred sheep to continuous infection with Trichostrongylus axei

Berg, J.Ann., 2002:
Immune restoration

Valdez, H., 2002:
Immune restoration after treatment of HIV-1 infection with highly active antiretroviral therapy (HAART)

Laurence, J., 2002:
Immune restoration and HAART: new clinical and in vitro data

French, M.A.; Lenzo, N.; John, M.; Mallal, S.A.; McKinnon, E.J.; James, I.R.; Price, P.; Flexman, J.P.; Tay-Kearney, M.L., 2001:
Immune restoration disease after the treatment of immunodeficient HIV-infected patients with highly active antiretroviral therapy

French, M.; Price, P., 2003:
Immune restoration disease in HIV patients: aberrant immune responses after antiretroviral therapy

Kühlbach, C.; da Luz, S.; Baganz, F.; Hass, V.C.; Mueller, M.M., 2018:
A Microfluidic System for the Investigation of Tumor Cell Extravasation

Borrè, S.; Brondolo, R.; Brustia, D.; Rosa, F.; Rizzo, G.; Garavelli, P.L., 2001:
Immune restoration syndrome

Wittram, C.; Fogg, J.; Farber, H., 2001:
Immune restoration syndrome manifested by pulmonary sarcoidosis

Del Giudice, P., 2002:
Immune restoration syndromes in human immunodeficiency virus infection

Bowers, M., 1995:
Immune restoration think tank 5

Lederman, M.M.; Valdez, H., 2000:
Immune restoration with antiretroviral therapies: implications for clinical management

James, J.S., 1995:
Immune restoration--conference outlines future directions

Kerman, R.H.; Kimball, P.M.; Lindholm, A.; Van Buren, C.T.; Katz, S.M.; Lewis, R.M.; Podbielski, J.; Williams, J.; Kahan, B.D., 1993:
Immune risk factors: impact on the incidence and diagnosis of rejection

Chiaroni, J.; Legrand, D., 2001:
Immune safety in blood transfusions

Daenke, S., 1997:
Immune selection and virus evolution: be cautious of paradigms

Miller, J.F., 2002:
Immune self-tolerance mechanisms

van den Bogaerde, J.; Kamm, M.A.; Knight, S.C., 2001:
Immune sensitization to food, yeast and bacteria in Crohn's disease

Starodub, V.M.; Fedorenko, L.L.; Sisets'kyĭ, A.P.; Kurs'kyĭ, M.D., 1999:
Immune sensor for determining myoglobin level

Schaible, U.E.; Wallich, R.; Kramer, M.D.; Gern, L.; Anderson, J.F.; Museteanu, C.; Simon, M.M., 1993:
Immune sera to individual Borrelia burgdorferi isolates or recombinant OspA thereof protect SCID mice against infection with homologous strains but only partially or not at all against those of different OspA/OspB genotype

Yoshida, H.; Nagai, T.; Kato, Y., 1996:
Immune serum tests. Sampling for complement tests--determination of serum complement hemolytic activity (CH50) and problems associated with handling of samples

Lu, X., 1993:
Immune state and traditional Chinese medicinal therapy of migraine

Chebotarev, V.F.; Komissarenko, I.V.; Zamotaeva, G.A.; Rybakov, S.I.; Kovalenko, A.E.; Stepura, N.N.; Kotliarenko, N.N.; Zakharchenko, T.F.; Zubkova, T.A.; Omel'chuk, A.V., 2000:
Immune state of patients of various age with the thyroid gland tumor

Ginsberg, H.S., 1971:
Immune states in long-term space flights

Valenzuela, M.T.; Vega, J.; Leal, I.; Vicente, M.; Young, V.; Vera, L.; Fasce, R.; Ramírez, E., 1999:
Immune status against measles and rubella among 4 Chilean groups of different ages

Kut'ko, I.I.; Frolov, V.M.; Pustovoĭ, I.G.; Rachkauskas, G.S., 1995:
Immune status and micro-hemodynamic function of patients with chronic alcoholism and liver pathology

Knoring, B.E., 1996:
Immune status characteristics as the basis for the prognosis of lung diseases

Gorbunov, V.I.; Gannushkina, I.V.; Likhterman, L.B., 1994:
Immune status dynamics in different lateralizations of focal traumatic brain lesions

Ewart, D.W.; Darby, S.C.; Lee, C.A.; Giangrande, P.L.; Spooner, R.J.; Phillips, A.N.; Ludlam, C.A., 1998:
Immune status in HIV-1-infected men and boys with haemophilia in the United Kingdom. UK Haemophilia Centre Directors' Organisation

Zemlianoĭ, A.B.; Pal'tsyn, A.A.; Svetukhin, A.M.; Kolokol'chikova, E.G.; Chervonskaia, N.V.; Badikova, A.K.; Bobrovnikov, A.E.; Puchkova, L.S.; Grishina, I.A., 2002:
Immune status in diabetic patients with pyo-necrotic lesions of lower extremities

Nazirov, P.Kh.; Ubaĭdullaev, A.M.; Vakhidova, G.A.; Pospelov, L.E., 1993:
Immune status in patients with bone and joint tuberculosis and effect of HLA genotype

Eliutin, D.V.; Sadchikov, D.V.; Arkhangel'skiĭ, S.M.; Zabrodskiĭ, P.F.; Shanina, N.Iu.; Sadchikova, G.D., 2002:
Immune status in the perioperative period in gestosis

Dutka, R.Ia.; Matushchak, O.M.; Hel'ker, Z.A.; Lapovets', L.E., 1998:
Immune status indices during the combined treatment of patients with duodenal peptic ulcer

Wang, Z.; Yao, P.; Song, Y.; Xu, H.; Wang, G.; Liu, Y., 2002:
Immune status of BALB/c mice and rubella virus JR23 strain infection of central nervous system

Chatrath, R.; Saili, A.; Jain, M.; Dutta, A.K., 1998:
Immune status of full-term small-for-gestational age neonates in India

Rudenko, V.P.; Loginskiĭ, V.E.; Kachorovskiĭ, B.V., 1994:
Immune status of hemophilia patients treated with blood preparations: laboratory and clinical assessment (review of the literature)

Mannucci, P.M.; Brettler, D.B.; Aledort, L.M.; Lusher, J.M.; Abildgaard, C.F.; Schwartz, R.S.; Hurst, D., 1994:
Immune status of human immunodeficiency virus seropositive and seronegative hemophiliacs infused for 3.5 years with recombinant factor VIII. The Kogenate Study Group

Adambekov, D.A.; Litvinov, V.I.; Mambetov, K.B.; Sabyrbekova, T.S.; Koshmuratov, A.G.; Chubakov, T.Ch., 1996:
Immune status of middle-aged and aged patients with tuberculosis

Malysheva, O.A.; Shirinskiĭ, V.S.; Kozhevnikov, V.S.; Evsiukova, E.V.; Starostina, N.M., 2001:
Immune status of patients with chronic bronchitis and neurocirculatory asthenia

Kunakbaeva, T.S.; Umarova, S.K.; Bakatova, A.I., 2002:
Immune status of patients with foot mycoses in combination with immunodeficiency

Frolov, V.M.; Peresadin, N.A.; Kazakova, S.E.; Safonova, E.F., 1993:
Immune status of people participating in the clean-up of after-effects of the Chernobyl Nuclear Power Plant accident living in the industrial region of Donbass

Pavlov, S.B.; Sidorenko, A.L.; Kratenko, I.S.; Pavlova, G.B., 2001:
Immune status of school children of 1st classes under different schooling conditions

Egorova, I.V.; Litovskaia, A.V., 1998:
Immune status of workers at a hydrolysis yeast plant

N'Gom, P.T.; Jaffar, S.; Ricard, D.; Wilkins, A.; Ariyoshi, K.; Morgan, G.; D.S.lva, A.P.; Whittle, H.C., 1998:
Immune stimulation by syphilis and malaria in HIV-2-infected and uninfected villagers in West Africa

Agnes, A.; Zippel, K.; Zuckermann, H.; Döcke, W.D.; Volk, H.D.; Müller, J.M., 1999:
Immune stimulation with G-CSF (Neupogen) in septic patients with immune paralysis

Dummer, R.; Yue, F.Y.; Pavlovic, J.; Geertsen, R.; Döhring, C.; Moelling, K.; Burg, G., 1998:
Immune stimulatory potential of B7.1 and B7.2 retrovirally transduced melanoma cells: suppression by interleukin 10

Chaouat, G.; Tranchot Diallo, J.; Volumenie, J.L.; Menu, E.; Gras, G.; Delage, G.; Mognetti, B.; Wegmann, T., 1997:
Immune suppression and Th1/Th2 balance in pregnancy revisited: a (very) personal tribute to Tom Wegmann

Schmitz, K.; Hitzer, S.; Behrens-Baumann, W., 2002:
Immune suppression by combination therapy with basiliximab and cyclosporin in high risk keratoplasty. A pilot study

Paape, M.J.; Shafer-Weaver, K.; Capuco, A.V.; Van Oostveldt, K.; Burvenich, C., 2000:
Immune surveillance of mammary tissue by phagocytic cells

Bechmann, I.; Priller, J.; Kovac, A.; Böntert, M.; Wehner, T.; Klett, F.F.; Bohsung, J.; Stuschke, M.; Dirnagl, U.; Nitsch, R., 2002:
Immune surveillance of mouse brain perivascular spaces by blood-borne macrophages

Folkers, G., 1996:
Immune system activation boosts HIV replication in HIV-infected people

Burkitt, K.; Aggarwal, S.K., 2000:
Immune system activation by CDDP and "poly-plat"

Abo, T.; Kawamura, T., 1997:
Immune system and diseases that vary with circumstance and physical condition

Kachi, T.; Igata, A., 1993:
Immune system and hypophysis

Sapin, M.R., 1999:
Immune system and immunodeficiency

Esposito, S., 2002:
Immune system and surgical site infection

Murata, S.; Tanaka, K., 2003:
Immune system and ubiquitin supersystem

Kuznetsov, S.I.; Semenova, I.V., 1997:
Immune system cells as mediators in the reaction of other body systems to stress exposure

Gostishchev, V.K.; Paukov, V.S.; Shkrob, L.O.; Germakova, N.G.; Shalchkova, L.P., 1996:
Immune system defence and its correction in patients with chronic inflammatory disorders of lower extremities

Descamps-Latscha, B.; Herbelin, A.; Nguyen, A.T.; Zingraff, J.; Jungers, P.; Chatenoud, L., 1994:
Immune system dysregulation in uremia

Solov'ev, A.M., 1996:
Immune system function and the efficacy of immunocorrective treatment in patients with a chronic persistent chlamydial infection

Driianskaia, V.E., 1998:
Immune system function in patients with acute pyelonephritis

Petrova, I.V.; Leshchenko, G.M.; Mol'kov, I.N.; Riabova, M.A.; Polosina, O.V.; Makovetskaia, A.K., 1998:
Immune system function in separate categories of the population

Ivanitskaia, N.F.; Savchenko, M.V.; Sorokina, S.F.; Li, I.B., 1996:
Immune system function in the participants in the cleanup of the aftermath of the accident at the Chernobyl Atomic Electric Power Station

Wansen, K.; Pastinen, T.; Kuokkanen, S.; Wikström, J.; Palo, J.; Peltonen, L.; Tienari, P.J., 1997:
Immune system genes in multiple sclerosis: genetic association and linkage analyses on TCR beta, IGH, IFN-gamma and IL-1ra/IL-1 beta loci

Lebl, J.; Sediva, A.; Snajderova, M.; Pruhova, S.; Rakosnikova, V., 2001:
Immune system in adults with childhood-onset growth hormone deficiency: effect of growth hormone therapy

Asfandiiarova, N.S.; Romadin, A.E.; Kolcheva, N.G.; Goncharenko, L.V.; Shatrov, V.V.; Saiamova, E.A.; Shmel'kova, N.B.; Shalkin, V.N., 1998:
Immune system in residents of territories contaminated with radionuclides after Chernobyl accident

Freeman, S.M.; Ramesh, R.; Marrogi, A.J., 1997:
Immune system in suicide-gene therapy

Hanson, L.A.; Silfverdal, S-Arne.; Korotkova, M.; Erling, V.; Strömbeck, L.; Olcén, P.; Ulanova, M.; Hahn-Zoric, M.; Zaman, S.; Ashraf, R.; Telemo, Eörn., 2002:
Immune system modulation by human milk

Ebrahim, G.J., 1999:
Immune system of the gut and the feeding of infants

Khaitov, R.M., 2000:
Immune system physiology

Dembic, Z., 2001:
Immune system protects integrity of tissues

Malyzhev, V.A.; Pelevina, I.I.; Afanasév, G.G.; Gordienko, S.M.; Gubriĭ, I.B.; Klimenko, T.I.; Lukashova, R.G.; Petrova, I.V.; Sergeeva, T.A., 1993:
Immune system status under effect of low levels of ionizing radiation:studies within the 10 kilometer zone of accident at Chernobyl nuclear plant

Orellana, C., 2002:
Immune system stimulator shows promise against tuberculosis

Kagawa, T.; Mekada, E.; Shishido, Y.; Ikenaka, K., 1998:
Immune system-related CD9 is expressed in mouse central nervous system myelin at a very late stage of myelination

Miyagi, T.; Tatsumi, T.; Hayashi, N., 2002:
Immune therapy against hepatocellular carcinoma using gene-modified tumor cells

Heslop, H.E.; Bollard, C.M.; Gottschalk, S.; Kuehnle, I.; Huls, M.H.; Gee, A.P.; Brenner, M.K.; Rooney, C.M., 2002:
Immune therapy for EBV infections after hemopoietic stem-cell transplant

Bunn, P.A., 1999:
Immune therapy for lung cancer: are we getting closer?

Singh, B.; Powrie, F.; Mortensen, N.J., 2001:
Immune therapy in inflammatory bowel disease and models of colitis

Molldrem, J., 2002:
Immune therapy of AML

Pol, S.; Michel, M.L.; Bréchot, C., 2000:
Immune therapy of hepatitis B virus (HBV) chronic infection. European experience

Pol, S.; Michel, M.L.; Bréchot, C., 2000:
Immune therapy of hepatitis B virus chronic infection

Anonymous, 2002:
Immune therapy: in brief

Shah, S.J.; Warrier, R.P.; Ode, D.L.; Lele, H.E.; Yu, L.C., 1996:
Immune thrombocytopenia and hemolytic anemia associated with Hodgkin disease

McCaulley, M.E., 1996:
Immune thrombocytopenia and ulcerative colitis: response to nonoperative therapy

Wensing, J.W.; Vlasveld, L.T., 1997:
Immune thrombocytopenia attributed to norfloxacin

Ikeda, K.; Shichishima, T.; Yui, T.; Sakai, K.; Ohtake, A.; Ishibashi, T.; Noji, H.; Maruyama, Y., 2002:
Immune thrombocytopenia in an elderly patient treated successfully by pulse therapy with cyclophosphamide

Schreiber, Z.A., 1997:
Immune thrombocytopenia in postpolythemic myelofibrosis

Bussel, J.B., 1998:
Immune thrombocytopenia in pregnancy: autoimmune and alloimmune

Kaplan, C., 2001:
Immune thrombocytopenia in the foetus and the newborn: diagnosis and therapy

Khouri, I.; Tuan, B.; Grant, K., 2002:
Immune thrombocytopenic purpura

Imbach, P.; Kühne, T., 1998:
Immune thrombocytopenic purpura ITP

Morselli, M.; Potenza, L.; Luppi, M.; Torelli, G.; Emilia, G., 2003:
Immune thrombocytopenic purpura and Helicobacter pylori infection

Pérez de Llano, L.A.; Soilán del Cerro, J.L.; García Pais, M.J., 1998:
Immune thrombocytopenic purpura as presenting form of miliary tuberculosis

Hernández-Maraver, D.; Peláez, J.; Pinilla, J.; Navarro, F.H., 1996:
Immune thrombocytopenic purpura due to disseminated tuberculosis

Anglin, B.V.; Rutherford, C.; Ramus, R.; Lieser, M.; Jones, D.B., 2001:
Immune thrombocytopenic purpura during pregnancy: laparoscopic treatment

Gillis, S.; Eldor, A., 1999:
Immune thrombocytopenic purpura in adults: clinical aspects

Hostynova, E.; Cap, J.; Lukac, J.; Raskova, J.; Kadrliakova, A.; Zednickova, N.; Bodova, I., 2002:
Immune thrombocytopenic purpura in children

Zeller, B.; Lie, S.O., 1996:
Immune thrombocytopenic purpura in children--controversy and consensus. How much investigation and treatment is meaningful?

Hord, J.D.; Whitlock, J.A.; Grossman, N.J., 1994:
Immune thrombocytopenic purpura in infants

Amigo, M.L.; Caballero, M.D.; Vazquez, L.; Flores, T.; López, A.; San Miguel, J.F., 1998:
Immune thrombocytopenic purpura secondary to endometriosis

Mitra, S.; Marwaha, N.; Marwaha, R.K.; Trehan, A.; Sehgal, S., 2000:
Immune thrombocytopenic purpura with multiple auto-antibodies: evolution into systemic lupus erythematosus

Miner, R.J.; Skoog, S.M., 2001:
Immune thrombocytopenic purpura, profuse diarrhea, and new onset ulcerative colitis: a dramatic response to splenectomy

Garderet, L.; Aoudjhane, M.; Bonte, H.; Lagrange, M.; Isnard, F.; Fouillard, L.; Najman, A., 2001:
Immune thrombocytopenic purpura: first symptom of gamma/delta T -cell lymphoma

Nugent, D.J., 1999:
Immune thrombocytopenic purpura: why treat?

Perkins, R.P., 1998:
Immune to the concept

Stremmel, C.; Klein, P.; Hohenberger, W., 2002:
Immune tolerance and active suppression in oncology. Immunological principles and therapeutic options

Pleyer, U.; Ritter, T.; Volk, H.D., 2000:
Immune tolerance and gene therapy in transplantation

Feuerstein, N.; Goldman, S.; Feuerstein, G., 2002:
Immune tolerance and stroke: a turning point

Anderson, D.E.; Hafler, D.A., 2001:
Immune tolerance and the nervous system

Landolfi, R.; de Cristofaro, R.; Lazzareschi, I.; Riccardi, R.; Mariani, G., 2001:
Immune tolerance by intermittent factor VIII boluses in two high responder hemophilia A patients

Damiano, M.L.; Hutter, J.J., 2000:
Immune tolerance for haemophilia patients with inhibitors: analysis of the western United States experience. The Tri-Regional Nursing Group

Brackmann, H.H.; Oldenburg, J.; Schwaab, R., 1996:
Immune tolerance for the treatment of factor VIII inhibitors--twenty years' 'bonn protocol'

Kurunczi, S.; Mark, I., 1993:
Immune tolerance in Masugi nephritis

Chuansumrit, A.; Pakakasama, S.; Kuhathong, K.; Chantanakajornfung, A.; Hathirat, P., 2000:
Immune tolerance in a haemophilia A patient with high inhibitor using locally prepared lyophilized cryoprecipitate

McKenzie, B.A.; Grover, W.H., 2017:
A microfluidic thermometer: Precise temperature measurements in microliter- and nanoliter-scale volumes

Mariani, G.; Kroner, B., 2000:
Immune tolerance in hemophilia and inhibitors: a cost analysis

Mariani, G.; Brackmann, H.H., 2001:
Immune tolerance in hemophilia and treatment of hemophiliacs with an inhibitor

Aledort, L.M., 1999:
Immune tolerance in hemophiliacs: can we afford it? Is it worth it? Baxter Previously Untreated Patient Study Group

Spina, V.; Aleandri, V.; Pacchiarotti, A.; Salvi, M., 1999 :
Immune tolerance in pregnancy. Maternal-fetal interactions

Berntorp, E.; Astermark, J.; Carlborg, E., 2001:
Immune tolerance induction and the treatment of hemophilia. Malmö protocol update

Rocino, A.; Papa, M.L.; Salerno, E.; Capasso, F.; Miraglia, E.; de Biasi, R., 2001:
Immune tolerance induction in haemophilia A patients with high-responding inhibitors to factor VIII: experience at a single institution

Unuvar, A.; Warrier, I.; Lusher, J.M., 2000:
Immune tolerance induction in the treatment of paediatric haemophilia A patients with factor VIII inhibitors

Brackmann, H.H.; Effenberger, W.; Hess, L.; Schwaab, R.; Oldenburg, J., 1999:
Immune tolerance induction: a role for recombinant activated factor VII (rFVIIa)?

Berntorp, E., 2001:
Immune tolerance induction: recombinant vs. human-derived product

Werner, J.A., 1997:
Immune tolerance of skin xenotransplants

Mariani, G.; Hilgartner, M.; Thompson, A.R.; Tusell, J.; Manco-Johnson, M.; Ghirardini, A.; Bellocco, R.; Brackmann, H.H., 1995:
Immune tolerance to Factor VIII: the international registry data

Haya, S.; López, M.F.; Aznar, J.A.; Batlle, J., 2001:
Immune tolerance treatment in haemophilia patients with inhibitors: the Spanish Registry

Ishizaka, K., 1994:
Immune tolerance, anergy, suppressor T cells

D.Michele, D.M., 1999:
Immune tolerance: a synopsis of the international experience

Barbas, C.F.; Heine, A.; Zhong, G.; Hoffmann, T.; Gramatikova, S.; Björnestedt, R.; List, B.; Anderson, J.; Stura, E.A.; Wilson, I.A.; Lerner, R.A., 1998:
Immune versus natural selection: antibody aldolases with enzymic rates but broader scope

Lipman, M.L.; Shen, Y.; Jeffery, J.R.; Gough, J.; McKenna, R.M.; Grimm, P.C.; Rush, D.N., 1999:
Immune-activation gene expression in clinically stable renal allograft biopsies: molecular evidence for subclinical rejection

Behrend, M., 2000:
Immune-adhesion molecules in the prevention of allograft rejection and reperfusion injury

Lein, B., 1995:
Immune-based therapies

Emery, S.; Lane, H.C., 1996:
Immune-based therapies in HIV infection: recent developments

Anonymous, 2002:
Immune-based therapies: a review of clinical endpoints used in trials of selected immunologic agents

Engle, J., 1996:
Immune-based therapy for HIV

Plaut, M., 2001:
Immune-based, targeted therapy for allergic diseases

Pulik, M.; Lionnet, F.; Genet, P.; Petitdidier, C.; Vacher, B., 1995:
Immune-complex glomerulonephritis associated with Staphylococcus aureus infection of a totally implantable venous device

Appel, G.B., 1993:
Immune-complex glomerulonephritis--deposits plus interest

Qiao, J.H.; Castellani, L.W.; Fishbein, M.C.; Lusis, A.J., 1993:
Immune-complex-mediated vasculitis increases coronary artery lipid accumulation in autoimmune-prone MRL mice

Lapidot, T.; Fajerman, Y.; Kollet, O., 1997:
Immune-deficient SCID and NOD/SCID mice models as functional assays for studying normal and malignant human hematopoiesis

Mehta, V.K.; Massad, M.G.; Tripathi, S.P.; Koshy, M.; Geha, A.S., 1999:
Immune-deficient bronchiectasis associated with X-linked lymphoproliferative disease

Wuttke, W.; Pitzel, L.; Knoke, I.; Theiling, K.; Jarry, H., 1997:
Immune-endocrine interactions affecting luteal function in pigs

Nussdorfer, G.G.; Mazzocchi, G., 1998:
Immune-endocrine interactions in the mammalian adrenal gland: facts and hypotheses

Heys, S.D.; Stott, S.A.; Noble, D.W., 2001:
Immune-enhancing diets

Zaloga, G.P., 1998:
Immune-enhancing enteral diets: where's the beef?

Dickerson, R.N., 1997:
Immune-enhancing enteral formulas in critically ill patients

Barton, R.G., 1997:
Immune-enhancing enteral formulas: are they beneficial in critically ill patients?

Zhang, H., 2000:
Immune-imbalance in sepsis

Nordström, D.; Santavirta, S.; Gristina, A.; Konttinen, Y.T., 1993:
Immune-inflammatory response in the totally replaced hip: a review of biocompatibility aspects

Ishikawa, N.; Horii, Y.; Nawa, Y., 1993:
Immune-mediated alteration of the terminal sugars of goblet cell mucins in the small intestine of Nippostrongylus brasiliensis-infected rats

Appel, S.H.; Smith, R.G.; Le, W.D., 1996:
Immune-mediated cell death in neurodegenerative disease

Raanani, P.; Ben-Bassat, I., 2002:
Immune-mediated complications during interferon therapy in hematological patients

Julkunen, H.; Kaaja, R.; Siren, M.K.; Mack, C.; McCready, S.; Holthöfer, H.; Kurki, P.; Maddison, P., 1998:
Immune-mediated congenital heart block (CHB): identifying and counseling patients at risk for having children with CHB

Charlesworth, E.N., 2000:
Immune-mediated dermatologic skin disorders in the senior patient

Liu, Z-Xu.; Kaplowitz, N., 2002:
Immune-mediated drug-induced liver disease

Reynolds, J.C., 1999:
Immune-mediated enteric neuron dysfunction in scleroderma

Bohnhorst, J.Ovrebø.; Hanssen, I.; Moen, T., 2003:
Immune-mediated fever in the dog. Occurrence of antinuclear antibodies, rheumatoid factor, tumor necrosis factor and interleukin-6 in serum

Ryan, A.F.; Harris, J.P.; Keithley, E.M., 2002:
Immune-mediated hearing loss: basic mechanisms and options for therapy

Rose, N.R., 2002:
Immune-mediated heart disease: in the footsteps of Jenner

Weiser, M.G.; Thrall, M.A., 1993:
Immune-mediated hemolytic anemia in dogs

Scott-Moncrieff, C., 2001:
Immune-mediated hemolytic anemia: 70 cases (1988-1996)

Lovera, Jús.; Hayes, A.; Brennan, K.; Adams-Hogan, F., 2002:
Immune-mediated inflammatory demyelinating dysfunction of the nervous system

Williams, J.P.; Meyers, J.A., 2003:
Immune-mediated inflammatory disorders (I.M.I.D.s): the economic and clinical costs

Cotter, C.S.; Singleton, G.T.; Corman, L.C., 1994:
Immune-mediated inner ear disease and parvovirus B19

García Berrocal, J.R.; Arellano, B.; Vargas, J.A.; Trinidad, A.; Ramírez Camacho, R.; Vergara, J., 1998:
Immune-mediated inner ear disease: report of clinical cases

Maheshwari, A.; Christensen, R.D.; Calhoun, D.A., 2002:
Immune-mediated neutropenia in the neonate

Ooi, J.; Takahashi, S.; Tajika, K.; Tojo, A.; Tani, K.; Asano, S., 1998:
Immune-mediated optic neuritis after unrelated allogeneic bone marrow transplantation

D.K.yser, F.; Naeyaert, J.M.; Hindryckx, P.; Elewaut, D.; Verplancke, P.; Peene, I.; Praet, M.; Veys, E., 2000:
Immune-mediated pathology following hepatitis B vaccination. Two cases of polyarteritis nodosa and one case of pityriasis rosea-like drug eruption

Ishizu, H.; Bove, K.E.; Ziegler, M.M.; Arya, G., 1994:
Immune-mediated regression of 'metastatic' neuroblastoma in the liver

Kanzaki, J., 1994:
Immune-mediated sensorineural hearing loss

Yeo, S.W.; Park, S.N., 2001:
Immune-mediated sensorineural hearing loss in a patient with ankylosing spondylitis: a case report

Veldman, J.E., 1998:
Immune-mediated sensorineural hearing loss with or without endolymphatic hydrops: a clinical and experimental approach

Day, M.J., 1998:
Immune-mediated thrombocytopenia

Porcelijn, L.; von dem Borne, A.E., 1999:
Immune-mediated thrombocytopenias: basic and immunological aspects

Zheng, F.; Li, L.; Liu, Z., 1996:
Immune-mediated tubulointerstitial injury in hemorrhagic fever with renal syndrome

Blumberg, A.; Stamm, B.; Wegmann, W.; Schaub, N., 1993:
Immune-mediated type A gastritis and glomerulonephritis

Hakkaart, G.A.; Chapman, M.D.; Aalberse, R.C.; van Ree, R., 1998:
Immune-reactivity of recombinant isoforms of the major house dust mite allergen Der p 2

Dana, M.R.; Wilensky, J.T., 1993:
Immune-related disease and normal-tension glaucoma

Veloso, F.T.; Carvalho, J.; Magro, F., 1996:
Immune-related systemic manifestations of inflammatory bowel disease. A prospective study of 792 patients

Mels, A.K.; Statius Muller, M.G.; van Leeuwen, P.A.; von Blomberg, B.M.; Scheper, R.J.; Cuesta, M.A.; Beelen, R.H.; Meijer, S., 2001:
Immune-stimulating effects of low-dose perioperative recombinant granulocyte-macrophage colony-stimulating factor in patients operated on for primary colorectal carcinoma

Møller, J.; Jacobsen, N.; Dickmeiss, E.; Svejgaard, A., 1999:
Immunephenotyping of T lymphocytes from patients after allogeneic bone marrow transplantation

Mariani, G.; Scheibel, E.; Nogao, T.; Kasper, C.K.; Ewing, N.P.; Mauser-Bunschoten, E.; Ghirardini, A.; Bellocco, R.; Brackman, H.H., 1994:
Immunetolerance as treatment of alloantibodies to factor VIII in hemophilia. The International Registry of Immunetolerance Protocols

Tateishi, J.; Kitamoto, T.; Kretzschmar, H.; Mehraein, P., 1996:
Immunhistological evaluation of Creutzfeldt-Jakob disease with reference to the type PrPres deposition

Orenstein, W.A., 1976:
Immunible diseases of childhood

Martin, J., 2002:

van Niekerk, J.P., 2002:
Immunisation AIDS

Hodgson, R.E.; Rocke, D.A.; Smith, A., 1995 :
Immunisation against hepatitis B viral infection--a study of South African anaesthesiologists

Anonymous, 1996:
Immunisation against infectious disease--1996 Edward Jenner Bicentenary Edition

Webb, N.J.; Fitzpatrick, M.M.; Hughes, D.A.; Brocklebank, T.J.; Judd, B.A.; Lewis, M.A.; Postlethwaite, R.J.; Smith, P.A.; Corbitt, G., 2000:
Immunisation against varicella in end stage and pre-end stage renal failure. Trans-Pennine Paediatric Nephrology Study Group

Balkundi, D.R.; Nycyk, J.A.; Cooke, R.W., 1994:
Immunisation and C reactive protein in infants on neonatal intensive care units

McIntyre, P.B.; O'Brien, E.D.; Heath, T.C., 1998:
Immunisation and asthma

Ciment, J., 1999:
Immunisation and counselling for Kosovar refugee children

Poutasi, K., 1996:
Immunisation and diabetes

Bolton, P., 2000:
Immunisation and socioeconomic disadvantage

Bhuyan, A.L., 2000:
Immunisation and the cold chain

Mitchell, E.A.; Stewart, A.W.; Clements, M., 1995:
Immunisation and the sudden infant death syndrome. New Zealand Cot Death Study Group

Anonymous, 1998:
Immunisation and vaccination for the under five-year-old

O'Connor, T., 2002:
Immunisation campaign almost completed

McIlvenny, S.; Barr, J., 2000:
Immunisation coverage at a well-baby clinic in the United Arab Emirates

Selvey, C., 2000:
Immunisation coverage estimates

Lister, S.; McIntyre, P.B.; Burgess, M.A.; O'Brien, E.D., 1999:
Immunisation coverage in Australian children: a systematic review 1990-1998

Bell, D.W.; Ford, R.P.; Slade, B.; McCormack, S.P., 1998:
Immunisation coverage in Christchurch in a birth cohort. Christchurch Immunisation Coordination Committee

Tuohy, P.G., 2000:
Immunisation coverage in New Zealand

Mathias, K., 2001:
Immunisation coverage in Tairawhiti

Hull, B.P.; McIntyre, P.B., 2000:
Immunisation coverage reporting through the Australian Childhood Immunisation Register--an evaluation of the third-dose assumption

Vinson, D.R., 2000:
Immunisation does not rule out tetanus

Teele, D.W., 1994:
Immunisation for Haemophilus influenzae type b and rates of meningitis due to this organism

Traynor, V.; Britt, H.; Bridges-Webb, C.; Sayer, G.P.; Meza, R.A.; Charles, J., 1996:
Immunisation in general practice. Results from the Australian Morbidity and Treatment Survey, 1990-1991

McIntyre, P.B.; Burgess, M.A.; Lester, R., 2000:
Immunisation in the age of the human genome

Burgess, M.A., 1997:
Immunisation in the year 2020 and beyond

Thomson, J.; Hilditch, A.; Pirkis, J.; Dunt, D., 2000:
Immunisation initiatives in general practice. Important lessons from division projects

Gerl, M.; Steinert, C.; Quint, M.; Schade, Rüdiger.; Günzler, V., 1996:
Immunisation of Chickens with the Aminoterminal Propeptide of Bovine Procollagen Type III (Specificity of egg yolk antibodies and comparison with immunoassays using rabbit and mouse antibodies

Kilmartin, M.R.; Woodward, D.R.; Leigh Blizzard, C.; Turner, K., 1998:
Immunisation of babies. The mothers' perspective

Leigh, J.A., 2002:
Immunisation of dairy cattle with recombinant Streptococcus uberis GapC or a chimeric CAMP antigen confers protection against heterologous bacterial challenge. M.C. Fontaine et al. [Vaccine 20 (2002) 2278-2286

Szabó, M.P.; Bechara, G.H., 1997:
Immunisation of dogs and guinea pigs against Rhipicephalus sanguineus ticks using gut extract

Bechara, G.H.; Szabó, M.P.; Mukai, L.S.; Rosa, P.C., 1994:
Immunisation of dogs, hamsters and guinea pigs against Rhipicephalus sanguineus using crude unfed adult tick extracts

Freund, I.; Dzapo, V.; Vielitz, E.; Redmann, T.; Kaleta, E.F., 2001:
Immunisation of fancy chickens against Newcastle disease

Marchand, M.; Punt, C.J.A.; Aamdal, S.; Escudier, B.; Kruit, W.H.J.; Keilholz, U.; Håkansson, L.; van Baren, N.; Humblet, Y.; Mulders, P.; Avril, M-F.; Eggermont, A.M.M.; Scheibenbogen, C.; Uiters, J.; Wanders, J.; Delire, M.; Boon, T.; Stoter, G., 2002:
Immunisation of metastatic cancer patients with MAGE-3 protein combined with adjuvant SBAS-2: a clinical report

Stankiewicz, M.; Cabaj, W.; Pernthaner, A.; Hadas, E., 1996:
Immunisation of sheep by drug-abbreviated infections of Ostertagia circumcincta and Trichostrongylus colubriformis against field challenge of gastro-intestinal nematodes

Smith, S.K.; Smith, W.D., 1996:
Immunisation of sheep with an integral membrane glycoprotein complex of Haemonchus contortus and with its major polypeptide components

Tjornehoj, K.; Lawrence, J.A.; Kafuwa, P.T.; Whiteland, A.P.; Chimera, B.A., 1997:
Immunisation of smallholder dairy cattle against anaplasmosis and babesiosis in Malawi

Karayiannis, P.; Saldanha, J.; Monjardino, J.; Jackson, A.; Luther, S.; Thomas, H.C., 1993:
Immunisation of woodchucks with hepatitis delta antigen expressed by recombinant vaccinia and baculoviruses, controls HDV superinfection

Polnay, L.; Horn, N., 1989:
Immunisation practice in an inner city clinic

Slack-Smith, L.M.; Read, A.W.; Stanley, F.J., 1999:
Immunisation rates in child care children

Yilmaz, H.; Roe, J.M.; Morgan, K.L., 1996:
Immunisation regimes used to elevate serum IgE in sheep

Duclos, P.; Hofmann, C.A., 2002:
Immunisation safety: a priority of the World Health Organization's Department of Vaccines and Biologicals

Sokhey, J., 1993:
Immunisation services in India

Schulpen, T.W.; van Seventer, A.H.; Rümke, H.C.; van Loon, A.M., 2002:
Immunisation status of children adopted from China

Pert, H., 1993:
Immunisation strategies

Schluter, P.J.; Ford, R.P., 1998:
Immunisation timeliness for a birth cohort in Christchurch. Christchurch Immunisation Coordination Study Group

Bond, L.; Nolan, T.; Lester, R., 1999:
Immunisation uptake, services required and government incentives for users of formal day care

Dagan, R., 2002:
Immunisation with a pneumococcal 7-valent conjugate vaccine

Pontesilli, O.; Aiuti, F., 1999:
Immunisation with gp160 in HIV-1 infection

Heussler, V.T.; Taracha, E.L.; Musoke, A.; Duchateau, L.; McKeever, D.J., 1998:
Immunisation with live attenuated Salmonella dublin expressing a sporozoite protein confers partial protection against Theileria parva

Anders, R.F.; Crewther, P.E.; Edwards, S.; Margetts, M.; Matthew, M.L.; Pollock, B.; Pye, D., 1998:
Immunisation with recombinant AMA-1 protects mice against infection with Plasmodium chabaudi

Walker, D., 1993:
Immunisation--125 years of progress

Kable, R.S.; Harris, M.F., 1997:
Immunisation--lifting our game

Kline, R., 1994:
Immunisation. At the sharp end

Bedford, H., 1993:
Immunisation. Facts and fiction

Anonymous, 2002:
Immunisation. Meningitis C vaccine programme hailed a success

Robinson, P.; Flood, M.; Spicer, M., 1997:
Immunisation. Myths and misconceptions

Coombes, R., 2002:
Immunisation. School nurses burnt out by meningitis C campaign

Navarro Alonso, J.A., 2002:
Immunisation: Leaps into the future. Vaccine studies at the start of the 21st century (I)

Luiz, S.M., 1994:
Immunisation: fiction versus fact

Howse, C., 1994:
Immunisation: flu jab

Alvarez Pasquín, M.J.; Saenz, D.L.F.ente, T., 2002:
Immunisation: leaps into the future. Primary Care vaccination: new aspects of an old activity

Mato Chaín, G.; Mariano Lázaro, A.; Rodríguez Caravaca, G.; Fereres Castiel, J., 2002:
Immunisation: leaps into the future. The flu virus and syncytial respiratory virus: strategies for active immunisation

Bayas, J.M.; Vilella, A., 2002:
Immunisation: leaps into the future. Viral hepatitis

Amadi, O.; Jackson, P., 2002:
Immunisation: productive but disruptive

Mansoor, O.D., 1996:
Immunisation: sacred cow or evidence based medicine?

Martin, J., 1996:
Immunisation: to protect yourself

Anonymous, 1998:
Immunise Australia program: measles control campaign

Moreton, J., 1999:
Immunising against influenza

Warner, J., 2000:
Immunising children is difficult for parents, but it is worse for nurses

Carnie, J., 1997:
Immunising the population. Are we succeeding?

Aebischer, T.; Laforsch, S.; Hurwitz, R.; Brombacher, F.; Meyer, T.F., 2000:
Immunity against Helicobacter pylori: significance of interleukin-4 receptor alpha chain status and gender of infected mice

Zhou, D.M.; Yi, X.Y.; Zeng, X.F.; Wang, M.; McReynolds, L., 2003:
Immunity against Schistosoma japonicum induced by phage display peptides mimicking antigenic epitopes of Trichinella spiralis

Walory, J.; Grzesiowski, P.; Hryniewicz, W., 2001:
Immunity against diphtheria and tetanus in the adult Polish population

Fordymacka, A., 2001:
Immunity against diphtheria and tetanus in various age groups after 40 years since implementation of the mass vaccination program

Lee, H.F.; Tseng, L.R.; Yueh, Y.Y.; Wu, Y.C., 2000:
Immunity against diphtheria in Taiwan

Puntarić, D.; Vodopija, I.; Baklaić, Z.; Ljubicić, M., 1995:
Immunity against hepatitis A in younger age groups and the basis for an immunization program

Post, J.J.; Freeman, A.J.; Harvey, C.E.; Ffrench, R.A.; Lloyd, A.R., 2002:
Immunity against hepatitis C virus infection

Ratnam, S.; West, R.; Gadag, V.; Williams, B.; Oates, E., 1996:
Immunity against measles in school-aged children: implications for measles revaccination strategies

Queral Casanova, R.G., 1994:
Immunity against rubella, tetanus and hepatitis B. A study among nursing students

Cilla, G.; Sáenz-Domínguez, J.R.; Montes, M.; Part, C.; Pérez-Trallero, E., 1994:
Immunity against tetanus in adults over the age of 49 years

Cilla Eguiluz, G.; Sáenz Domínguez, J.R.; Urbieta Egaña, M.; Carcedo Michelena, A.; Pérez Trallero, E., 1993:
Immunity against tetanus in childhood

Yagita, H., 1993:
Immunity and cell adhesion molecules

Lindstrøm, T.C., 1997:
Immunity and health after bereavement in relation to coping

Oleson, D.R.; Magee, R.M.; Donahoe, R.M.; Falek, A.; Coles, C.D., 1998:
Immunity and prenatal alcohol exposure. A pilot study in human adolescents

Golding, B.; Scott, D.E.; Scharf, O.; Huang, L.Y.; Zaitseva, M.; Lapham, C.; Eller, N.; Golding, H., 2001:
Immunity and protection against Brucella abortus

Gaughran, F., 2002:
Immunity and schizophrenia: autoimmunity, cytokines, and immune responses

Peluso, G.; Mansi, L., 2001:
Immunity and somatostatin receptors

Derevenco, P., 1997:
Immunity and stress

Lloyd, A.R.; Wakefield, D.; Hickie, I., 1993:
Immunity and the pathophysiology of chronic fatigue syndrome

Anonymous, 1976:
Immunity and the suppression of reproductive systems

Brown, T.A., 1996:
Immunity at mucosal surfaces

Suárez, J.; Castañeda, M.R.; Gutiérrez, C.B.; Rodríguez Barbosa, J.I.; Tascón, R.I.; Rodríguez Ferri, E.F., 1993:
Immunity coverage against measles, rubella and parotiditis viruses in a juvenile population in Leon, Spain

Vercruysse, J.; Claerebout, E., 1998:
Immunity development against Ostertagia ostertagi and other gastrointestinal nematodes in cattle

Sakaeva, D.D.; Lazareva, D.N., 1999:
Immunity during ampicillin administration against a background of immunosuppression

Farci, P.; Orgiana, G.; Purcell, R.H., 1995:
Immunity elicited by hepatitis C virus

Bock, R.E.; de Vos, A.J., 2002:
Immunity following use of Australian tick fever vaccine: a review of the evidence

O'Shea, K.P., 1991:
Immunity for peer review under the Health Care Quality Improvement Act of 1986

Rhodes, A.M., 1996:
Immunity for reporting child abuse

Roeder, K.H., 1997:
Immunity for state employed physicians left uncertain after Keenan decision

Dickinson, M.L.; Weinstein, K.R., 1995:
Immunity from criminal prosecution for parents who withhold medically necessary treatment from children on religious grounds

Anonymous, 1982:
Immunity from liability; actions against parents on childbirth claims; defenses and damages in third party actions

Wright, B., 1994:
Immunity from pain

Azambuja, P.; Feder, D.; Mello, C.; Gomes, S.; Garcia, E., 2000:
Immunity in Rhodnius prolixus: trypanosomatid-vector interactions

Długońska, H., 2000:
Immunity in Toxoplasma gondii infections

Pedersen, B.K.; Rohde, T.; Zacho, M., 1996:
Immunity in athletes

Eysker, M.; Kooyman, F.N.; Ploeger, H.W., 2002:
Immunity in calves against Dictyocaulus viviparus following a low primary infection

Sergeev, A.Iu.; Burova, S.A., 2001:
Immunity in candidosis and immune correction

Sereda, A.D.; Kotliarov, V.M.; Vorob'ev, A.A.; Bakulov, I.A., 2001:
Immunity in listeriosis

Yamashita, M.; Aikawa, A., 2000:
Immunity in maintenance immunosuppression with and without cyclosporine in long-term kidney transplant recipients

D.H.rdt, P.; Haesebrouck, F.; Devriese, L.A.; Ducatelle, R., 1994:
Immunity in pigeons against homologous and heterologous serotypes of Streptococcus bovis after infection

Dodet, 2000:
Immunity in the elderly

Kehrli, M.E.; Harp, J.A., 2001:
Immunity in the mammary gland

Wong, J.Y.; Opdebeeck, J.P., 1993 :
Immunity in vaccinated cattle exposed to experimental and natural infestations with Boophilus microplus

Schleifer, S.J.; Keller, S.E.; Bartlett, J.A.; Eckholdt, H.M.; Delaney, B.R., 1996:
Immunity in young adults with major depressive disorder

Knoring, B.E.; Titarenko, O.T.; Sakharova, I.Ia.; Loginova, G.P.; D'iakova, M.E.; Perova, T.L.; Simbirtsev, A.S.; Pigareva, N.V.; Kotov, A.Iu., 2003:
Immunity indicators and the degree of adenosine deaminase activity in patients with pulmonary tuberculosis

Frolov, V.M.; Germanov, V.T.; Peresadin, N.A., 1993:
Immunity indices in the diagnosis of persistent HBs-antigenemia in pregnant women

Strobel, S., 2002:
Immunity induced after a feed of antigen during early life: oral tolerance v. sensitisation

Guo, H.; Chen, G.; Lu, F.; Chen, H.; Zheng, H., 2002:
Immunity induced by DNA vaccine of plasmid encoding the rhoptry protein 1 gene combined with the genetic adjuvant of pcIFN-gamma against Toxoplasma gondii in mice

Streliaeva, A.V.; Buniatan, N.D.; Samylina, I.A.; Sadykov, V.M.; Sadykov, R.V.; Biriukov, I.V.; Ibadova, D.N., 2002:
Immunity induced by immunomodulators during echinococcal immunosuppression

Lorenzen, N.; Lorenzen, E.; Einer-Jensen, K.; LaPatra, S.E., 2001:
Immunity induced shortly after DNA vaccination of rainbow trout against rhabdoviruses protects against heterologous virus but not against bacterial pathogens

Slusarczyk, J.; Dulny, G.; Nowak, K.; Krszyna, J.; Wysokińska, T.; Fordymacka, A.; Gzyl, A.; Janaszek, Wława.; Gniadek, G., 2002:
Immunity of children aged 6-8 against pertussis, tetanus and diphtheria

Adambekov, D.A.; Litvinov, V.I.; Mambetov, K.B.; Koshmuratov, A.G.; Sabyrbekova, T.S., 1998:
Immunity of middle age and aged patients with tuberculosis and its changes during multimodality treatment by using T-activin

Borcić, B.; Kruzić, V.; Kaić, B.; Ljubin-Sternak, S.; Ljubicić, M.; Dobrovsak-Sourek, V., 1999:
Immunity of the Croatian population to poliomyelitis--a serosurvey

Riethmuller, D.; Seilles, E., 2001:
Immunity of the female genital tract mucosa and mechanisms of papillomavirus evasion

Elufimova, V.F.; Mitinskaia, L.A.; Iukhimenko, N.V.; Romanova, R.Iu.; Abramova, Z.P.; Dem'ianenko, N.V.; Baenskiĭ, A.V., 2000:
Immunity parameters in children with prior intrathoracic tuberculosis

Anonymous, 2001:
Immunity provisions: they must be read carefully. Ironside v. Simi Valley Hospital

Sabbattini, P.; Six, E.; Zangrossi, S.; Briani, F.; Ghisotti, D.; Deho, G., 1996:
Immunity specificity determinants in the P4-like retronphage phi R73

Novikov, I.A.; Kon'kov, S.Kh.; Shumilov, E.I., 1994:
Immunity state of oncological patients during long-term treatment with tramal

Diedrich, S.; Claus, H.; Schreier, E., 2002:
Immunity status against poliomyelitis in Germany: determination of cut-off values in International Units

Panikratov, K.D.; Polozov, V.V.; Strel'nikov, A.I.; Sotnikova, N.Iu., 2001:
Immunity status in early postoperative complications in children with anomalies of kidneys and upper urinary tract

Mills, K.H., 2001:
Immunity to Bordetella pertussis

Penttilä, T.; Vuola, J.M.; Puurula, V.; Anttila, M.; Sarvas, M.; Rautonen, N.; Mäkelä, P.H.; Puolakkainen, M., 2001:
Immunity to Chlamydia pneumoniae induced by vaccination with DNA vectors expressing a cytoplasmic protein (Hsp60) or outer membrane proteins (MOMP and Omp2)

Perry, L.L.; Feilzer, K.; Caldwell, H.D., 1997:
Immunity to Chlamydia trachomatis is mediated by T helper 1 cells through IFN-gamma-dependent and -independent pathways

Cotter, T.W.; Byrne, G.I., 1996:
Immunity to Chlamydia: comparison of human infections and murine models

North, R.J.; Conlan, J.W., 1998:
Immunity to Listeria monocytogenes

Abraham, D.; Lucius, R.; Trees, A.J., 2002:
Immunity to Onchocerca spp. in animal hosts

Chatterjee, S.; François, G.; Druilhe, P.; Timperman, G.; Wéry, M., 1996:
Immunity to Plasmodium berghei exoerythrocytic forms derived from irradiated sporozoites

Nolan, T.J.; Rotman, H.L.; Bhopale, V.M.; Schad, G.A.; Abraham, D., 1995:
Immunity to a challenge infection of Strongyloides stercoralis third-stage larvae in the jird

Taylor-Robinson, A., 1999:
Immunity to asexual blood stages of: is resistance to acute malaria adaptive or innate? - a response

Corbeil, L.B.; BonDurant, R.H., 2001:
Immunity to bovine reproductive infections

Musharrafieh, U.M.; Nuwayhid, I.A.; Hamadeh, G.N.; Steitieh, S.W.; Bizri, A.R.N., 2003:
Immunity to chickenpox among school adolescents in Lebanon and options for vaccination

Egemen, A.; Kurugöl, Z.; Akşit, S.; Ozacar, T.; Keskinoğlu, P.; Afşar, I., 2001:
Immunity to diphtheria in Izmir, Turkey

Miller, E.; Rush, M.; Morgan-Capner, P.; Hutchinson, D.; Hindle, L., 1994:
Immunity to diphtheria in adults in England

Borcić, B.; Milosević, T.S.; Mlinarić, A.D.; Dobrovsak-Sourek, V.; Ljubicić, M.; Gotovac, P., 1996:
Immunity to diphtheria in the Croatian population in 1994

Goullin, B.; Wallet, F.; Sanson, Y.; Decoster, A.; Duhamel, M.; Courcol, R., 1999:
Immunity to diphtheria in the North of France

Thygesen, P.; Brandt, L.; Jørgensen, T.; Christensen, H.B.; Hougen, H.P.; Jensen, E.T.; Rygaard, J., 1994:
Immunity to experimental Salmonella typhimurium infections in rats. Transfer of immunity with primed CD4+CD25high and CD4+CD25low T lymphocytes

Thygesen, P.; Christensen, H.B.; Hougen, H.P.; Rygaard, J., 1996:
Immunity to experimental Salmonella typhimurium infections in rats. Transfer of immunity with primed CD45RC+ and CD45RC- CD4 T-cell subpopulations

German, T.P.; Defeyter, M.A., 2001:
Immunity to functional fixedness in young children

Tian, B.; Zhao, B.; Feng, F.; Luo, F.; Zhou, H.; Ge, X.; Yanhong, W.; Li, X., 2018:
A micro gas chromatographic column with embedded elliptic cylindrical posts

Kenna, J.G.; Knight, T.L.; van Pelt, F.N., 1993:
Immunity to halothane metabolite-modified proteins in halothane hepatitis

van Eden, W., 1999:
Immunity to heat shock proteins and arthritic disorders

Birnbaum, G.; Kotilinek, L., 1999:
Immunity to heat shock proteins and neurological disorders of women

Witkin, S.S., 1999:
Immunity to heat shock proteins and pregnancy outcome

Reid, A.E.; Friedman, L.S., 1994:
Immunity to hepatitis B virus: passing the torch

Battegay, M., 1996:
Immunity to hepatitis C virus: a further piece of the puzzle

Kamili, S., 2002:
Immunity to hepatitis E virus: new insights and future challenges

Rouse, B.T.; Gierynska, M., 2002:
Immunity to herpes simplex virus: a hypothesis

Franco, M.A.; Greenberg, H.B., 2000:
Immunity to homologous rotavirus infection in adult mice

Greaves, 1999:
Immunity to infection genetic effects on immunity HIV

Bernatowska, E., 2002:
Immunity to infection. Infection in primary immunodeficiency

Kaufmann, S.H., 1993:
Immunity to intracellular bacteria

Taylor-Robinson, A., 2001:
Immunity to malaria increases during puberty

Germanaud, J., 1994:
Immunity to measles among health care workers in France

Robbins, J.B.; Schneerson, R.; Bryla, D.A.; Trollfors, B.; Taranger, J.; Lagergård, T., 1999:
Immunity to pertussis. Not all virulence factors are protective antigens

Chaisavaneeyakorn, S.; Moore, J.M.; Otieno, J.; Chaiyaroj, S.C.; Perkins, D.J.; Shi, Y.Ping.; Nahlen, B.L.; Lal, A.A.; Udhayakumar, V., 2002:
Immunity to placental malaria. III. Impairment of interleukin(IL)-12, not IL-18, and interferon-inducible protein-10 responses in the placental intervillous blood of human immunodeficiency virus/malaria-coinfected women

Hogg, K.; Hogg, G.; Lester, R.; Uren, E., 2002:
Immunity to poliomyelitis in Victorians

Muñoz González, F.; Sánchez Muñoz, C.; González Sánchez, M.; Sánchez Laínez, J.; López de Castro, F.; Rufino Portillo, G., 1996:
Immunity to rubella in pregnant women in the health area of Toledo

Abdel-Fattah, M.M.; el-Gindy, A.E.; Hegab, M.H.; el-Mohammed, F.; Shahin, A.M.; el-Gohary, F.; Omar, O.M.; Khater, N., 2003:
Immunity to schistosomiasis before puberty: humeral or cell mediated

Ulèová-Gallová, Z.; Krauz, V.; Mohamed, A.M.; Rokyta, Z., 1999:
Immunity to spermatozoa and male fertility

Cumberland, N.S.; Kidd, A.G.; Karalliedde, L., 1993:
Immunity to tetanus in United Kingdom populations

Aboud, S.; Lyamuya, E.F.; Kristoffersen, E.K.; Matre, R., 2002:
Immunity to tetanus in male adults in Dar es Salaam, Tanzania

Stroffolini, T.; Giammanco, A.; Giammanco, G.; Taormina, S.; Maggio, M.; Genovese, M.; De Mattia, D.; Chiaramonte, M.; Scarpa, B.; Genovese, R., 1997:
Immunity to tetanus in the 3-20 year age group in Italy

Avrahami-Heller, Y.; Cohen, D.; Orr, N.; Slepon, R.; Ashkenazi, I.; Danon, Y.L., 2000:
Immunity to varicella zoster virus in young Israeli adults

Best, J.M.; Palmer, S.J.; Hesketh, L.; Morgan-Capner, P.; Mathers, K., 1994:
Immunity to viral infections among medical students in London

Elson, C.J.; Thompson, S.J., 1994:
Immunity, autoimmunity and immunotherapy: new frontiers in heat shock protein research

Aguilar Parada, E.; Rábago Velasco, M.; Aguilar Ibarra, M.T.; Moreno Cano, H., 1993:
Immunity, the trophoblast and decidua

Overgaauw, P.A., 1996:
Immunity--technical aspects of vaccines. I. Immunoprophylaxis in dogs and cats

Berhanel, Y.; Bekele, A.; Tesfaye, F., 2001:
Immunization (EPI) in Ethiopia: acceptance, coverage, and sustainability

Wang, G., 1996:
Immunization Concerns for Asian Americans and Pacific Islanders

de la Cámara, R.; Bischofberger, C.; Campins, M.; Carreras, E., 1998:
Immunization after hematopoietic stem cell transplantation: review and recommendations. Subcommittee of the Spanish Group on Infectious Complications in Hematopoietic Transplantation (GETH) and the Spanish Society of Preventive Medicine, Public Health and Hygiene

Frenkel, D.; Katz, O.; Solomon, B., 2000:
Immunization against Alzheimer's beta -amyloid plaques via EFRH phage administration

Mbassa, G.K.; Kweka, L.E.; Dulla, P.N., 1998:
Immunization against East Coast Fever in field cattle with low infectivity Theileria parva stabilate--preliminary assessment

Garpenholt, O.; Fredlund, H.; Timpka, T., 2002:
Immunization against Haemophilus influenzae type b in Sweden--a study of the introduction process

Kiefel, V.; Vicariot, M.; Breitfeld, C.; Giptner, A.; Schlüter, C.; Böhringer, M.; Santoso, S.; Kroll, H.; Mueller-Eckhardt, C., 1994:
Immunization against a new, infrequent alloantigen (Iy) on the platelet glycoprotein Ib/IX as a cause of a serious case of neonatal alloimmune thrombocytopenia

Deshaies, D.; Dion, R.; Valiquette, L.; Auger, N., 1998:
Immunization against hepatitis A during an outbreak in a Jewish Orthodox community--Quebec, 1997-1998

McCluskie, M.J.; Wen, Y.M.; Di, Q.; Davis, H.L., 1999:
Immunization against hepatitis B virus by mucosal administration of antigen-antibody complexes

Osen, W.; Jochmus, I.; Müller, M.; Gissmann, L., 2000:
Immunization against human papillomavirus infection and associated neoplasia

Buzinova, E.V.; Slesareva, Z.E.; Obukhova, M.F.; Ashmarin, I.P., 1998:
Immunization against monoamine oxidase slows extinction of a conditioned active escape reflex in rats

Anonymous, 1994 :
Immunization against pneumococcal infection. U.S. Public Health Service

Sun, W.; IJdo, J.W.; Telford, S.R.; Hodzic, E.; Zhang, Y.; Barthold, S.W.; Fikrig, E., 1998:
Immunization against the agent of human granulocytic ehrlichiosis in a murine model

Ling, I.T.; Ogun, S.A.; Momin, P.; Richards, R.L.; Garçon, N.; Cohen, J.; Ballou, W.R.; Holder, A.A., 1997:
Immunization against the murine malaria parasite Plasmodium yoelii using a recombinant protein with adjuvants developed for clinical use

Durrant, L.G.; Spendlove, I., 2002:
Immunization against tumor cell surface complement-regulatory proteins

Copeland, V.C., 1996:
Immunization among African American children: implications for social work

Byahuka, E., 1994:
Immunization and HIV / AIDS

Mapp, C.E.; Lucchini, R.E.; Miotto, D.; Chitano, P.; Jovine, L.; Saetta, M.; Maestrelli, P.; Springall, D.R.; Polak, J.; Fabbri, L.M., 1998:
Immunization and challenge with toluene diisocyanate decrease tachykinin and calcitonin gene-related peptide immunoreactivity in guinea pig central airways

Matthews, T., 1998:
Immunization and cot death

Corbeil, L.B., 1999:
Immunization and diagnosis in bovine reproductive tract infections

Teichmann, K.D., 1997:
Immunization and global ecology

Grabenstein, J.D., 2001:
Immunization and organ transplant donors and recipients

Anonymous, 2002:
Immunization and private sector participation

Hughes, R.A.; Choudhary, P.P.; Osborn, M.; Rees, J.H.; Sanders, E.A., 1996:
Immunization and risk of relapse of Guillain-Barré syndrome or chronic inflammatory demyelinating polyradiculoneuropathy

Anonymous, 2002:
Immunization and the prevention of influenza and pneumococcal disease in people with diabetes

Anonymous, 2000:
Immunization and the prevention of influenza and pneumococcal disease in people with diabetes: American Diabetes Association

Teitelbaum, M.A.; Edmunds, M., 1999:
Immunization and vaccine-preventable illness, United States, 1992 to 1997

Scofield, R.H.; James, J.A., 2000:
Immunization as a model for systemic lupus erythematosus

Cowchock, S.; Smith, J.B., 1994:
Immunization as therapy for recurrent spontaneous abortion: a review and meta-analysis

Stets, K.; Harper, P.; Christensen, R., 1996:
Immunization audits and protocols. Valuable tools to improve rates

Zimmerman, R.K.; Janosky, J.E., 1993:
Immunization barriers in Minnesota private practices: the influence of economics and training on vaccine timing

Gamertsfelder, D.A.; Zimmerman, R.K.; DeSensi, E.G., 1994 :
Immunization barriers in a family practice residency clinic

Traynor, K., 2001:
Immunization campaign targets influenza, meningitis, tetanus

Brown, S.G.; Simon, K.A.; Riddle, E.K.; Koucky, L.; Fuller, S.G.; Lobo, M.L., 1996:
Immunization carnivals for the hard-to-reach

Butterfoss, F.D.; Webster, J.D.; Morrow, A.L.; Rosenthal, J., 1998:
Immunization coalitions that work: training for public health professionals

Fredrickson, D.D.; Kies, K.M.; Burbach, C.A., 1997:
Immunization compliance among public and private school children

Petry, L.J., 1993:
Immunization controversies

Blackford, J.K., 2002:
Immunization controversy: understanding and addressing public misconceptions and concerns

al-Sheikh, O.G.; al-Samarrai, J.I.; al-Sumaidaie, M.M.; Mohammad, S.A.; al-Dujaily, A.A., 2000:
Immunization coverage among children born between 1989 and 1994 in Saladdin Governorate, Iraq

Vellucci, L., 2002:
Immunization coverage for measles, mumps and rubella in Italy: many shadows, few lights

Singh, P.; Yadav, R.J., 1998:
Immunization coverage in Bihar

Ahmad, N.; Akhtar, T.; Roghani, M.T.; Ilyas, H.M.; Ahmad, M., 2000:
Immunization coverage in three districts of North West Frontier Province (NWFP)

Anonymous, 1994:
Immunization coverage rates among two-year-olds in Kansas

Brugha, R.; Kevany, J., 1995:
Immunization determinants in the eastern region of Ghana

Faix, R.G., 2002:
Immunization during pregnancy

Giammanco, G.; Pignato, S.; Taormina, S.; Genovese, M.; Maggio, M.; Giammanco, A.; Anfuso, S.; Pittalà, D.; L.V.lti, S.; Soncini, R., 1997:
Immunization efficacy and tolerance of a tetravalent vaccine against diphtheria, tetanus, pertussis (acellular) and hepatitis B

Anonymous, 1977:
Immunization experts foresee problems

Gurwitz, D., 2001:
Immunization for Alzheimer's disease: yet closer to clinical trials

Xu, L.; Sanchez, A.; Yang, Z.; Zaki, S.R.; Nabel, E.G.; Nichol, S.T.; Nabel, G.J., 1998:
Immunization for Ebola virus infection

Baddour, 2000:
Immunization for Prevention of Infective Endocarditis

Schönfeld, C., 1999:
Immunization for adults in foreign travel

Marec-Bérard, P.; Floret, D.; Schell, M.; Mialou, V.; Frappaz, D.; Philip, T.; Bergeron, C., 2001:
Immunization for children treated for solid tumors: what are the guidelines?

Hall, C.B., 1993:
Immunization for hepatitis B infection: interest, information, and initiative?

Karthikeyan, G., 1998:
Immunization for hepatocellular carcinoma

Cohen, P.J., 1998:
Immunization for prevention and treatment of cocaine abuse: legal and ethical implications

Bratzler, D.W.; Christiaens, B.F.; Hempstead, K.; Nichol, K.L., 2003:
Immunization for seniors

Streefland, P.H., 1996:
Immunization from a socio-scientific viewpoint

Ofosu-amaah, S.; Shah, K.P., 1985:
Immunization glossary

Fivush, B.A.; Neu, A.M., 1998:
Immunization guidelines for pediatric renal disease

Elias, J.B., 1994:
Immunization in Benin

Bartůnĕk, P.; Mrázek, V., 1999:
Immunization in Lyme borreliosis--initial experience

Anonymous, 1993:
Immunization in Mongolia: where are the people?

Marwaha, R.K., 2000:
Immunization in cancer

John, 2000:
Immunization in cancer - reply

Schaberg, T.; Lode, H., 1994:
Immunization in pneumology

Bernatowska-Matuszkiewicz, E.; Socha, J.; Gajewska, E.; Ceglecka-Tomaszewska, K.; Szczuka, I., 1995:
Immunization in preterm and term infants

Melgaard, B., 2001:
Immunization in the 21st century--the way forward

Nokes, D.J.; Cutts, F.T., 1993:
Immunization in the developing world: strategic challenges

Classen, J.B.; Classen, D.C., 1999:
Immunization in the first month of life may explain decline in incidence of IDDM in The Netherlands

Smith, D.R., 2000:
Immunization in the new millennium: meeting the challenge to realize the promise

Anonymous, 1994:
Immunization initiative

Levin, J.E.; Giebink, G.S., 1994:
Immunization initiatives

Ohta, L.C., 1978:
Immunization injuries: proposed compensatory mechanisms--an analysis

Davis, R.L.; Rubanowice, D.; Shinefield, H.R.; Lewis, N.; Gu, D.; Black, S.B.; DeStefano, F.; Gargiullo, P.; Mullooly, J.P.; Thompson, R.S.; Chen, R.T., 1999 :
Immunization levels among premature and low-birth-weight infants and risk factors for delayed up-to-date immunization status. Centers for Disease Control and Prevention Vaccine Safety Datalink Group

Kahane, S.M.; Watt, J.P.; Newell, K.; Kellam, S.; Wight, S.; Smith, N.J.; Reingold, A.; Adler, R., 2000:
Immunization levels and risk factors for low immunization coverage among private practices

Grabenstein, J.D., 1998:
Immunization motivation: a vital pharmacy service

Anonymous, 2002:
Immunization news

Hefeneider, S.H.; Brown, L.E.; McCoy, S.L.; Bakke, A.C.; Cornell, K.A.; Bennett, R.M., 1993:
Immunization of BALB/c mice with a monoclonal anti-DNA antibody induces an anti-idiotypic antibody reactive with a cell-surface DNA binding protein

Baszler, T.V.; McElwain, T.F.; Mathison, B.A., 2000:
Immunization of BALB/c mice with killed Neospora caninum tachyzoite antigen induces a type 2 immune response and exacerbates encephalitis and neurological disease

Gajewski, T.F.; Fallarino, F.; Ashikari, A.; Sherman, M., 2001:
Immunization of HLA-A2+ melanoma patients with MAGE-3 or MelanA peptide-pulsed autologous peripheral blood mononuclear cells plus recombinant human interleukin 12

Ringrose, J.H.; Yard, B.A.; Verjans, G.M.; Boog, C.J., 1996:
Immunization of HLA-B27 transgenic and non transgenic mice with Salmonella typhimurium results predominantly in the generation of proliferative T cell responses

Achata, C.W., 1992:
Immunization of Mexican migrant farm worker's children, on site at a day care center in a rural Tennessee county: three successful summers

Kumar, H.; Gupta, A.; Gupta, V., 2018 :
A microinvasive technique for management of corneal edema secondary to glaucoma drainage device tube-corneal touch

Singh, K.; Ahn, C-Won.; Paik, E.; Bae, J.Won.; Lee, C-Hee., 2018:
A Micro-Level Data-Calibrated Agent-Based Model: The Synergy between Microsimulation and Agent-Based Modeling

Joyce, J.C.; Carroll, T.D.; Collins, M.L.; Chen, M-Hsin.; Fritts, L.; Dutra, J.C.; Rourke, T.L.; Goodson, J.L.; McChesney, M.B.; Prausnitz, M.R.; Rota, P.A., 2018:
A Microneedle Patch for Measles and Rubella Vaccination Is Immunogenic and Protective in Infant Rhesus Macaques

Gardner, P.; Schaffner, W., 1993:
Immunization of adults

Kimbi, H.K.; Fagbenro-Beyioku, A.F., 1995:
Immunization of albino mice using chloroquine attenuated Plasmodium yoelli nigeriensis

da Silva Vaz, I.; Logullo, C.; Sorgine, M.; Velloso, F.F.; Rosa de Lima, M.F.; Gonzales, J.C.; Masuda, H.; Oliveira, P.L.; Masuda, A., 1999:
Immunization of bovines with an aspartic proteinase precursor isolated from Boophilus microplus eggs

Knutson, K.L.; Schiffman, K.; Cheever, M.A.; Disis, M.L., 2002:
Immunization of cancer patients with a HER-2/neu, HLA-A2 peptide, p369-377, results in short-lived peptide-specific immunity

Wanjohi, J.M.; Ngeranwa, J.N.; Rumberia, R.M.; Muraguri, G.R.; Mbogo, S.K., 2002:
Immunization of cattle against East Coast fever using Theileria parva (Marikebuni) and relaxation of tick control in North Rift, Kenya

Ghosh, S.; Khan, M.H., 2000:
Immunization of cattle against Hyalomma anatolicum anatolicum using larval antigens

Schrijver, R.S.; Langedijk, J.P.; Keil, G.M.; Middel, W.G.; Maris-Veldhuis, M.; Van Oirschot, J.T.; Rijsewijk, F.A., 1997:
Immunization of cattle with a BHV1 vector vaccine or a DNA vaccine both coding for the G protein of BRSV

Peleg, B.A.; Samina, I.; Brenner, J., 1993:
Immunization of chickens with live Newcastle disease vaccine adjuvanted with oil

Barratt-Boyes, S.M.; Vlad, A.; Finn, O.J., 1999:
Immunization of chimpanzees with tumor antigen MUC1 mucin tandem repeat peptide elicits both helper and cytotoxic T-cell responses

Anonymous, 2000:
Immunization of college students against meningococcal disease

Pastor-Satorras, R.; Vespignani, A., 2002:
Immunization of complex networks

Das, G.; Ghosh, S.; Khan, M.H.; Sharma, J.K., 2001:
Immunization of cross-bred cattle against Hyalomma anatolicum anatolicum by purified antigens

Bienek, D.R.; Plouffe, D.A.; Wiegertjes, G.F.; Belosevic, M., 2002:
Immunization of goldfish with excretory/secretory molecules of Trypanosoma danilewskyi confers protection against infection

Prabhakar, P.; Irons, B.; Figueroa, J.P.; de Quadros, C., 2001:
Immunization of health care workers in the CARICOM countries

Keys, T.E.; Williams, W.W., 1988:
Immunization of health care workers: new concepts. Forum

Anonymous, 1998:
Immunization of health-care workers: recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Hospital Infection Control Practices Advisory Committee (HICPAC)

Nakayama, H.; Inaba, T.; Nargis, M.; Chisty, M.; Ito, M.; Kamiya, H., 1999:
Immunization of laboratory animals with ultraviolet-attenuated larvae against homologous challenge infection with Trichinella britovi

Dittmer, U.; Bodemer, W.; Hunsmann, G.; Voss, G., 1994:
Immunization of macaque monkeys with low- and high-dose regimens of SIVmac results in different immune responses

McCaffery, M.; Yao, T.J.; Williams, L.; Livingston, P.O.; Houghton, A.N.; Chapman, P.B., 1996:
Immunization of melanoma patients with BEC2 anti-idiotypic monoclonal antibody that mimics GD3 ganglioside: enhanced immunogenicity when combined with adjuvant

Yao, T.J.; Meyers, M.; Livingston, P.O.; Houghton, A.N.; Chapman, P.B., 1999:
Immunization of melanoma patients with BEC2-keyhole limpet hemocyanin plus BCG intradermally followed by intravenous booster immunizations with BEC2 to induce anti-GD3 ganglioside antibodies

Schoof, D.D.; Smith, J.W.; Disis, M.L.; Brant-Zawadski, P.; Wood, W.; Doran, T.; Johnson, E.; Urba, W.J., 1999:
Immunization of metastatic breast cancer patients with CD80-modified breast cancer cells and GM-CSF

Kalfayan, L.H.; Farhat, D.; El-Nakat, H.; Matar, G.M.; Abdelnoor, A.M., 2002:
Immunization of mice against Salmonella typhimurium using different DNA preparations

Gern, L.; Rais, O.; Capiau, C.; Hauser, P.; Lobet, Y.; Simoen, E.; Voet, P.; Pêtre, J., 1994:
Immunization of mice by recombinant OspA preparations and protection against Borrelia burgdorferi infection induced by Ixodes ricinus tick bites

Hartz, D.; Langhorne, J., 1994:
Immunization of mice with Escherichia coli containing an antigen of the malaria parasite Plasmodium chabaudi chabaudi expressed in lambda gt11 induces high antibody titres

Raponi, G.; Nazzari, G.; Lun, M.T.; Lorino, G.; Valentini, T.; Bronzini, M.; Gaeta, A.; Mancini, C.; Filadoro, F., 1991:
Immunization of mice with antibiotic treated Escherichia coli

Shrayer, D.P.; Bogaars, H.; Hearing, V.J.; Wanebo, H.J., 1996:
Immunization of mice with irradiated melanoma tumor cells transfected to secrete lymphokines and coupled with IL-2 or GM-CSF therapy

Cao, J.; Liu, S., 2002:
Immunization of mice with native tropomyosins from Schistosoma japonicum and Oncomelania hupensis

Xie, W.K.; Chen, Q.Y.; Wang, Q.B.; Pan, W.Q.; Yan, R.H.; Lu, D.R., 2000:
Immunization of mice with plasmid DNA against malaria and regulation of antigen expression by tetracycline-controlled promoter

Oliveira, S.C.; Splitter, G.A., 1996:
Immunization of mice with recombinant L7/L12 ribosomal protein confers protection against Brucella abortus infection

Tincani, A.; Gilburd, B.; Abu-Shakra, M.; Blank, M.; Allegri, F.; Ottaviani, R.; Riboni, M.; Meroni, P.L.; Balestrieri, G.; Shoenfeld, Y., 2002:
Immunization of naive BALB/c mice with human beta2-glycoprotein I breaks tolerance to the murine molecule

Van Rompay, K.K.A.; Greenier, J.L.; Cole, K.Stefano.; Earl, P.; Moss, B.; Steckbeck, J.D.; Pahar, B.; Rourke, T.; Montelaro, R.C.; Canfield, D.R.; Tarara, R.P.; Miller, C.; McChesney, M.B.; Marthas, M.L., 2002:
Immunization of newborn rhesus macaques with simian immunodeficiency virus (SIV) vaccines prolongs survival after oral challenge with virulent SIVmac251

Steffen, R., 1999:
Immunization of peacekeeping forces

Wesley, R.D.; Woods, R.D., 1993:
Immunization of pregnant gilts with PRCV induces lactogenic immunity for protection of nursing piglets from challenge with TGEV

Minor, P.D., 1997:
Immunization of pregnant women could protect babies from vaccine associated poliomyelitis

Peter, G., 1993:
Immunization of preterm infants

Edelman, R.; Russell, R.G.; Losonsky, G.; Tall, B.D.; Tacket, C.O.; Levine, M.M.; Lewis, D.H., 1993:
Immunization of rabbits with enterotoxigenic E. coli colonization factor antigen (CFA/I) encapsulated in biodegradable microspheres of poly (lactide-co-glycolide)

Mumcuoglu, K.Y.; Ben-Yakir, D.; Ochanda, J.O.; Miller, J.; Galun, R., 1998:
Immunization of rabbits with faecal extract of Pediculus humanus, the human body louse: effects on louse development and reproduction

Kazancioğlu, R.; Sever, M.S.; Yüksel-Onel, D.; Eraksoy, H.; Yildiz, A.; Celik, A.V.; Kayacan, S.M.; Badur, S., 2000:
Immunization of renal transplant recipients with pneumococcal polysaccharide vaccine

Anonymous, 1996:
Immunization of the adult patient in the emergency department. American College of Emergency Physicians

Lawton, A.R., 1994:
Immunization of the neonate

D'Angio, C.T., 1999:
Immunization of the premature infant

Lu, M.; Hilken, G.; Kruppenbacher, J.; Kemper, T.; Schirmbeck, R.; Reimann, J.; Roggendorf, M., 1998:
Immunization of woodchucks with plasmids expressing woodchuck hepatitis virus (WHV) core antigen and surface antigen suppresses WHV infection

Squarcione, S., 2000 :
Immunization of workers in medical environment

Lewit, E.M.; Mullahy, J., 1994:
Immunization of young children

Ikeda, R.M.; Birkhead, G.S.; Parsons, P.L.; Noonan, C.; Bunn, G., 1996:
Immunization outreach at Income Support Centers, New York City, 1992-1993

Goldstein, K.P.; Lauderdale, D.S.; Glushak, C.; Walter, J.; Daum, R.S., 1999:
Immunization outreach in an inner-city housing development: reminder-recall on foot

Bradford, B.J., 1999:
Immunization practices

Smith, S.W.; Connery, P.; Knudsen, K.; Scott, K.L.; Frintner, M.P.; Outlaw, G.; Weingart, S., 1999:
Immunization practices and beliefs of physicians in suburban Cook County, Illinois

Hanson, I.C.; Spears, W.; Jenkins, K.; Stoner, D., 1996:
Immunization prevalence rates for infants in a large urban center: Houston/Harris County, 1993

Crombie, D.L., 1983:
Immunization procedures in Europe

Narramore, J., 1999:
Immunization program update

Brenzel, L.; Claquin, P., 1994:
Immunization programs and their costs

Pérez-Cuevas, R.; Reyes, H.; Pego, U.; Tomé, P.; Ceja, K.; Flores, S.; Gutiérrez, G., 1999:
Immunization promotion activities: are they effective in encouraging mothers to immunize their children?

Piffer, S.; Moghadam, P.Fateh., 2002:
Immunization promotion in adults and the elderly: needs, evidence, and operative proposals for health services

Millar, J.S.; McCauley, D.; Mitchell, L.; Winston, T.; Hays, C., 2000:
Immunization rate comparison for Oklahoma Medicaid managed care population by age two: 1995-1998

Cowell, J.M.; Cowell, M.E., 2000:
Immunization rates: a community assessment approach for diagnosis

Altemeier, W.A., 1998:
Immunization rates: where is the help when we need it?

Spork, K.D.; Mutz, I., 1998:
Immunization recommendations for children and adults

Jessee, R.A., 1999:
Immunization refusal and physician responsibility

McKenna, V.B.; Sager, A.; Gunn, J.E.; Tormey, P.; Barry, M.Anita., 2002:
Immunization registries: costs and savings

Linkins, R.W., 2001:
Immunization registries: progress and challenges in reaching the 2010 national objective

Linkins, R.W.; Feikema, S.M., 1998:
Immunization registries: the cornerstone of childhood immunization in the 21st century

Anonymous, 2002:
Immunization registry progress--United States, 2002

Anonymous, 2002:
Immunization registry use and progress--United States, 2001

Gregorio, D.I.; S.J.hn, T.Y.; Baker, K.M.; Christison-Lagay, J.; O'Connor, D.; Gunas, H., 1997:
Immunization registry: problems and prospects for boosting vaccine coverage of children

Stenvig, T.E., 2002:
Immunization resources

Scholtz, M.; Duclos, P., 2000:
Immunization safety: a global priority

Anonymous, 2002:
Immunization schedule 2000

Anonymous, 1994:
Immunization schedule in PAHO member countries

Vernon, M.E.; Bryan, G.; Hunt, P.; Allensworth, D.; Bradley, B., 1997:
Immunization services for adolescents within comprehensive school health programs

Steiner, J.F.; Lowery, N.E.; Siegel, C.D.; Barton, P.L.; Goodspeed, J.R., 1996:
Immunization services in rural areas

Prislin, R.; Dyer, J.A.; Blakely, C.H.; Johnson, C.D., 1998:
Immunization status and sociodemographic characteristics: the mediating role of beliefs, attitudes, and perceived control

Srivastava, S.P.; Israil, M., 1995:
Immunization status in hospitalized children with acute paralytic poliomyelitis

Narramore, J., 2001:
Immunization status of 2-year-old children, year 2000 survey results

Salsberry, P.J.; Nickel, J.T.; Mitch, R., 1994:
Immunization status of 2-year-olds in middle/upper- and lower-income populations: a community survey

Lopreiato, J.O.; Moriarty, R., 1993:
Immunization status of a military dependent population

Schulte, J.M.; Burkham, S.; Squires, J.E.; Doran, T.; Hamaker, D.W.; Pelosi, J.; Graper, J.; Davis, R.; Caldwell, M.B., 2000:
Immunization status of children born to human immunodeficiency virus (HIV)-infected mothers in two Texas cities

Bradford, B.J.; Benedum, K.J.; Heald, P.A.; Petrie, S.E., 1996:
Immunization status of children on school entry: area analysis and recommendations 1991

John, T.J., 1996:
Immunization status of hospitalized children with acute paralytic poliomyelitis

Miller, L.C.; Comfort, K.; Kely, N., 2001:
Immunization status of internationally adopted children

Bradford, B.J.; Heald, P.A., 1996:
Immunization status of poor children

Jones, W.S.; Hall, B.H.; Smalley, J.R.; Schelonka, R.L.; Butzin, C.A.; Ascher, D.P., 1994:
Immunization status of preschool children in a military clinic

Tandon, M.; Nayar, D.; Ramachandran, S.; Kapil, U., 1999:
Immunization status of severely malnourished children in two ICDS projects of Rajasthan state--a pilot study

Jones-Lecointe, A.; Swanston, W.M.; Charles, W.P.; Simeon, D., 2002:
Immunization status of thirty patients with sickle cell disease five years post hepatitis B vaccination. A comparison with normal controls

Anonymous, 2002:
Immunization still critical to Canadian public health

Lewis-Bell, K., 2001:
Immunization still saves lives

Reece, S.M., 1993:
Immunization strategies for the elimination of hepatitis B

Thorburn, K.M.; Bohorques, R.; Stepak, P.; Smith, L.L.; Jobb, C.; Smith, J.P., 2002:
Immunization strategies to control a community-wide hepatitis A epidemic

Downs, G., 2002:
Immunization strategies within managed care

Pass, R.F., 1996:
Immunization strategy for prevention of congenital cytomegalovirus infection

Brown, L.M., 1993:
Immunization strategy worked

Golombek, S.G.; Gilmore, G.L.; Paradise, N.F., 1998:
Immunization survey in Iowa

Duclos, P.; Arruda, H.; Dessau, J.C.; Dion, R.; Dupont, M.; Gaulin, C.; Grenier, J.L.; Savard, M.; Trudeau, G.; Douville-Fradet, M.; Beauséjour, D.; Bergeron, A.; Bergeron, J.P.; Castonguay, M.; Clermont, P.; Cloutier, J.; Côté, L.; Czyziw, E.; Dubuc, M.; D'Halewyn, M.A.; Fortin, A.; Frigon, M.; Gélinas, M.; Kirouac, I.; Venne, S., 1996:
Immunization survey of non-institutionalized adults--Quebec (as of May 30, 1996)

Houri-Haddad, Y.; Soskoine, W.A.; Shapira, L., 2001:
Immunization to Porphyromonas gingivalis enhances the local pro-inflammatory response to subcutaneous bacterial challenge

Buzinova, E.V.; Slesareva, Z.E.; Obukhova, M.F.; Ashmarin, I.P., 1997:
Immunization to monoamine oxidase slows the extinction of the active avoidance conditioned reflex in rats

Oxman, M.N., 1995:
Immunization to reduce the frequency and severity of herpes zoster and its complications

Davis, R.L.; Black, S.; Vadheim, C.; Shinefield, H.; Baker, B.; Pearson, D.; Chen, R., 1997:
Immunization tracking systems: experience of the CDC Vaccine Safety Datalink sites

Wisniewski, T.; Sigurdsson, E.M., 2002:
Immunization treatment approaches in Alzheimer's and prion diseases

Dychkowski, L., 2002:
Immunization update for fall 2002

Anonymous, 1997:
Immunization update insert

Maxim, R.B., 2002:
Immunization update, 2002

Mawn, B.; Pakkala, K., 2000:
Immunization update: a community-based nursing education program

Cuninghame, C.J.; Charlton, C.P.; Jenkins, S.M., 1994:
Immunization uptake and parental perceptions in a strictly orthodox Jewish community in north-east London

Hawkins, W.G.; Gold, J.S.; Dyall, R.; Wolchok, J.D.; Hoos, A.; Bowne, W.B.; Srinivasan, R.; Houghton, A.N.; Lewis, J.J., 2000:
Immunization with DNA coding for gp100 results in CD4 T-cell independent antitumor immunity

McClements, W.L.; Armstrong, M.E.; Keys, R.D.; Liu, M.A., 1996:
Immunization with DNA vaccines encoding glycoprotein D or glycoprotein B, alone or in combination, induces protective immunity in animal models of herpes simplex virus-2 disease

Arora, A.; Seth, P., 2002:
Immunization with HIV-1 subtype B gp160-DNA induces specific as well as cross reactive immune responses in mice

de Oliveira, D.M.; do Carmo, S.A.; Silva-Teixeira, D.N.; Goes, A.M., 1999:
Immunization with PIII, a fraction of Schistosoma mansoni soluble adult worm antigenic preparation, affects nitric oxide production by murine spleen cells

Haqqi, T.M.; Qu, X.M.; Anthony, D.; Ma, J.; Sy, M.S., 1996:
Immunization with T cell receptor V beta chain peptides deletes pathogenic T cells and prevents the induction of collagen-induced arthritis in mice

Anthony, D.D.; Heeger, P.S.; Haqqi, T.M., 2001:
Immunization with TCR Vbeta10 peptide reduces the frequency of type-II collagen-specific Th1 type T cells in BUB/BnJ (H-2q) mice

Chang, M.; Walker, S.E.; Hoffman, R.W., 2001:
Immunization with a bacterial ATP-binding cassette transporter fragment suppresses autoimmunity and prolongs survival in MRL/lpr lupus-prone mice

Boykins, R.A.; Ardans, J.A.; Wahl, L.M.; Lal, R.B.; Yamada, K.M.; Dhawan, S., 2001:
Immunization with a novel HIV-1-Tat multiple-peptide conjugate induces effective immune response in mice

Zaks, T.Z.; Rosenberg, S.A., 1998 :
Immunization with a peptide epitope (p369-377) from HER-2/neu leads to peptide-specific cytotoxic T lymphocytes that fail to recognize HER-2/neu+ tumors

Costa, F.; Franchin, G.; Pereira-Chioccola, V.L.; Ribeirão, M.; Schenkman, S.; Rodrigues, M.M., 1998:
Immunization with a plasmid DNA containing the gene of trans-sialidase reduces Trypanosoma cruzi infection in mice

Joshi, A.; Sharma, B.; Goel, A.C.; Mondal, B., 2002:
Immunization with a plasmid DNA expressing rinderpest virus hemagglutinin protein protects rabbits from lethal challenge

Gern, L.; Hu, C.M.; Voet, P.; Hauser, P.; Lobet, Y., 1997:
Immunization with a polyvalent OspA vaccine protects mice against Ixodes ricinus tick bites infected by Borrelia burgdorferi ss, Borrelia garinii and Borrelia afzelii

Gravekamp, C.; Kasper, D.L.; Madoff, L.C., 1997:
Immunization with a single-repeat alpha C protein may prevent escape of lower repeat mutants of group B Streptococcus

Mattsson, L.; Lorentzen, J.C.; Svelander, L.; Bucht, A.; Nyman, U.; Klareskog, L.; Larsson, P., 1998:
Immunization with alum-collagen II complex suppresses the development of collagen-induced arthritis in rats by deviating the immune response

Toranzo, A.E.; Santos, Y.; Barja, J.L., 1997:
Immunization with bacterial antigens: Vibrio infections

Grubeck-Loebenstein, B.; Blasko, I.; Marx, F.K.; Trieb, I., 2000:
Immunization with beta-amyloid: could T-cell activation have a harmful effect?

Kumaraguru, U.; Gierynska, M.; Norman, S.; Bruce, B.D.; Rouse, B.T., 2001:
Immunization with chaperone-peptide complex induces low-avidity cytotoxic T lymphocytes providing transient protection against herpes simplex virus infection

Lee, H.Hoan.; Cha, S.Chul.; Jang, D.June.; Lee, J.Keun.; Choo, D.Wan.; Kim, Y.Sik.; Uh, H.Sun.; Kim, S.Young., 2002:
Immunization with combined HSV-2 glycoproteins B2 : D2 gene DNAs: protection against lethal intravaginal challenges in mice

Ni, H.T.; Spellman, S.R.; Jean, W.C.; Hall, W.A.; Low, W.C., 2001:
Immunization with dendritic cells pulsed with tumor extract increases survival of mice bearing intracranial gliomas

Mascola, J.R.; Snyder, S.W.; Weislow, O.S.; Belay, S.M.; Belshe, R.B.; Schwartz, D.H.; Clements, M.L.; Dolin, R.; Graham, B.S.; Gorse, G.J.; Keefer, M.C.; McElrath, M.J.; Walker, M.C.; Wagner, K.F.; McNeil, J.G.; McCutchan, F.E.; Burke, D.S., 1996:
Immunization with envelope subunit vaccine products elicits neutralizing antibodies against laboratory-adapted but not primary isolates of human immunodeficiency virus type 1. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group

Osanto, S.; Brouwenstÿn, N.; Vaessen, N.; Figdor, C.G.; Melief, C.J.; Schrier, P.I., 1993:
Immunization with interleukin-2 transfected melanoma cells. A phase I-II study in patients with metastatic melanoma